USRE36634E - Optical system for treatment of vascular lesions - Google Patents

Optical system for treatment of vascular lesions Download PDF

Info

Publication number
USRE36634E
USRE36634E US08/711,685 US71168596A USRE36634E US RE36634 E USRE36634 E US RE36634E US 71168596 A US71168596 A US 71168596A US RE36634 E USRE36634 E US RE36634E
Authority
US
United States
Prior art keywords
skin
cooling
iaddend
iadd
radiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US08/711,685
Inventor
Shahriar Ghaffari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US08/711,685 priority Critical patent/USRE36634E/en
Application granted granted Critical
Publication of USRE36634E publication Critical patent/USRE36634E/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/203Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser applying laser energy to the outside of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00057Light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00747Dermatology
    • A61B2017/00756Port wine stains
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • A61B2018/00029Cooling or heating of the probe or tissue immediately surrounding the probe with fluids open
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452Skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B2018/1807Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using light other than laser radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B2018/2255Optical elements at the distal end of probe tips
    • A61B2018/2266Optical elements at the distal end of probe tips with a lens, e.g. ball tipped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B2018/2255Optical elements at the distal end of probe tips
    • A61B2018/2272Optical elements at the distal end of probe tips with reflective or refractive surfaces for deflecting the beam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0059Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit
    • A61F2007/0063Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit for cooling
    • A61F2007/0064Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit for cooling of gas
    • A61F2007/0065Causing evaporation

Definitions

  • the present invention relates to an optical system for treatment of disorders of the skin, especially vascular lesions, such as Port Wine Stains.
  • PortWine Stains are congenital disorders of the skin in which vascular malformations produce red-colored isolated lesions occurring most commonly on the face, trunk and neck.
  • the lesion is basically an area of localized enlarged and ectatic blood vessels in the upper dermis.
  • PWS tends to progress from a pale pink and flat lesions in childhood to nodular and dark red-purple lesions in adulthood. Its unpleasant cosmetic appearance causes psychological stress and makes the patient seek medical help.
  • the goal of PWS treatment is to restore the normal color of the skin by selectively destroying the enlarged blood vessels while keeping the rest of the cutaneous structures intact.
  • the prior art method of choice for treatment of PWS is photocoagulation of the enlarged blood vessels.
  • absorption of the laser light by hemoglobin increases the temperature of the abnormal blood vessels until coagulation of blood and vessel walls takes place.
  • Wavelengths for treatment of PWS are usually selected because of their high absorption by hemoglobin.
  • the argon laser with lines at 488 and 514.4 nm has been selected for treatment of PWS because of its high absorption in blood.
  • Recently better coupling has been achieved by matching a pulse dye laser to the 577 nm peak of oxygenated hemoglobin.
  • coagulation of the enlarged vessels has been demonstrated at other wavelengths such as 1.06 and 10.6 ⁇ m.
  • laser treatment should selectively destroy dermal blood vessels up to a depth of approximately 0.6 mm without causing damage to the epidermis, and especially to the epidermal-dermal layer since damage to this layer disturbs the healing process and may lead to scarring.
  • Epidermal melanin is also an important chromophore with strong absorption in the ultraviolet that decreases through the visible spectrum. Melanin, therefore, has been a potential barrier for the incident laser light causing hearing of the epidermis and reducing the amount of light which reaches the underlying blood vessels.
  • One of the most recent lasers for the treatment of PortWine Stain is the pulsed dye laser tuned to 577 nm, which is at one of the high absorption peaks of hemoglobin. At 577 nm absorption by epidermal melanin and scattering by the dermis is lower than at the 540 nm peak or at argon wavelengths. The rate of heat generation is higher in the blood vessels than in the epidermis. Although pulse durations of 1 ⁇ s or less cause microvascular hemorrhage, 360 ⁇ s pulses seem to be very effective in causing selective vascular damage without excessive damage to the epidermis or non-vascular dermal structure.
  • a pulsed dye laser system is expensive for an average Dermatologist with a limited purchasing power.
  • the coherence of the laser beam is not a critical consideration as long as a light source with proper powers at the right wavelengths can be focused onto the skin with spot sizes in the range of 3-5 mm in diameter (similar to the spot sizes reported in such applications).
  • the tunable dye laser based systems have been very effective in exploring the mechanisms of the PWS treatments.
  • the purchasing cost of such laser based systems is approximately $150,000 and the annual maintenance is estimated to be $25,000 per laser system. Consequently, most Dermatologists can not justify the high cost of purchasing a laser based systems for this application.
  • Another cost consideration is the patients who may not be able to afford the high costs of such treatments. Therefore, there is a need for a low-cost system to achieve the same treatment for a much lower cost than the present treatment cost.
  • Such a system is provided by the present invention, described in greater detail below.
  • the present invention provides an improved optical system for treatment of disorders of the skin, especially vascular lesions, such as PortWine Stains.
  • the system comprises means for irradiating the skin with radiation at a predetermined wavelength.
  • the system also comprises means for cooling the skin during a predetermined time interval in coordination with delivery of the radiation.
  • the absorption of the radiation by the skin and the change in temperature of the skin is monitored by the system and the operation of the radiation delivery system is controlled to optimize treatment of the vascular lesion.
  • the source of irradiation is an arc lamp.
  • the means for cooling comprises a system for delivering a cooling gas to a lens in contact with the skin.
  • the cooling gas can be carbon dioxide, freon, or any other appropriate gas.
  • the lens used in the preferred embodiment is formed of sapphire.
  • FIG. 1 is an illustration of a blood vessel in relation to the dermis and epidermis.
  • FIG. 2 is a graphical illustration of the volumetric heat generated in skin as a function of depth for 500 nm light.
  • FIG. 3 is a graphical illustration of the absorption of light produce by an arc lamp by blood.
  • FIG. 4 is a graphical illustration of the spectral emission of a Mercury-Xenon arc lamp.
  • FIG. 5 is a graphical illustration the rate of heat generation as a function of wavelength of irradiation for blood, dermis and epidermis.
  • FIG. 6 is a graphical illustration of skin absorption and scattering characteristics.
  • FIGS. 7a-7b is an illustration of the preferred embodiment of the system for delivering radiation to the skin in accordance with the present invention.
  • FIGS. 8a-8d is an illustration of alternate embodiments of the system for delivering radiation to the skin in accordance with the present invention.
  • FIG. 9 is an illustration of a computer based control system for controlling the rate of irradiation of the treatment area.
  • FIG. 10 is a graphical illustration of the effects of cooling on skin.
  • FIG. 11 is a graphical illustration of volumetric heat generated in skin as a function of depth for irradiation at 577 nm.
  • FIG. 12 is the maximum dermal depth as a function of wavelength where the heat production at the top of the blood vessel is larger than at the epidermal-dermal junction using Monte Carlo and Kubelka-Munk theories.
  • FIG. 13 is a graphical illustration of skin temperature as a function of depth for cooling at various rates.
  • FIGS. 14a-14b are flow charts of the control and processing steps implemented in the system of the present invention.
  • the skin can be represented by two layers: a thin absorbing layer (epidermis) and predominantly scattering layer (dermis), as shown in FIG. 1.
  • the enlarged blood vessels in PWS are located mainly at a distance of 0.3 to 0.6 mm from the epidermal-dermal junction. Blood vessels are typically modeled as either a thin absorbing layer or as individual cylinders or spheres.
  • the goal of PWS treatment is to restore the normal color of the skin by selectively destroying the enlarged blood vessels while keeping the rest of the cutaneous structures intact.
  • the rate of heat generation S[W/cm 3 ] in the tissue due to absorption of radiation is:
  • ⁇ a is the local absorption coefficient and ⁇ (z) is the fluence rate.
  • the rate of heat generation at 500 nm is shown in FIG. 2.
  • the wavelength spectrum of lasers presently used for PWS treatment vary from 488 nm up to 590 nm with the optimum treatment at 585 nm.
  • FIG. 3 which is the blood absorption characteristic as a function of wavelength, reveals that the absorption of blood (HbO and Hb) is not sharp in a small neighborhood of the selected laser wavelengths.
  • the advantage of using a dye laser at 585 nm appears to be the higher penetration depths with minimal epidermal heating and scarring. It has been suggested that an argon laser would perform better if the heat could be removed from the surface.
  • the light source employed in the present invention is a "Mercury Vapor Arc lamp" with a wavelength characteristic shown in FIG. 4.
  • other light sources may be utilized, such as a xenon arc lamp.
  • Arc lamp power ratings up to 10,000 watts are commercially available.
  • an Arc lamp with a power rating of 2500 watts would produce sufficient light intensity for vascular lesion treatments.
  • An important characteristic of the lamp is that it produces two narrow linewidths of light about the peaks of 546 and 579 nm, which coincide with blood absorption peaks at 540 and 577 nm.
  • the lamp spectral distribution with respect to the blood absorption spectrum is shown in FIG. 3.
  • the Full Width Half Maximum (FWHM) of the lamp peak at 579 is 10 nm and at 546 is 6 nm.
  • the present invention includes a temperature compensation and monitoring system, discussed in greater detail below, to reduce the epidermal and dermal temperatures such that the overall system produces, in the epidermis and dermis, temperatures at least as low as the dye lasers at 577 or 585 nm.
  • FIG. 3 is the blood absorption coefficient in the range of 450-600 nm with the corresponding characteristic of the Arc lamp spectrum. The resultant rate of heat generation in blood, epidermis and dermis are shown in FIG. 5.
  • the difference in the rate of heat generation in the epidermis and dermis for Arc lamp irradiation will result in higher temperatures as compared to the dye laser at 577 and 585 nm at equal irradiance. Since the epidermal heat generation is approximately 3.5 times that of dermis, the dermis will always be at lower temperatures than epidermis. As a result, the temperature of epidermis must be lowered during the Arc lamp irradiation to remove the excess heat generated. The worst case heating of the epidermis is the case of using only 500 nm irradiation.
  • the epidermal temperature increase using a dye laser is assumed to be approximately 20° C.
  • the epidermis temperature must be brought down approximately 15° C. below the normal skin temperature, before irradiation. This is the worst case situation in using the Arc lamp.
  • the system of the present invention is capable of cooling the skin to temperatures as low as 5° C., which is more than the cooling capability needed for this treatment.
  • the delivery device 10 comprises a housing 12 containing optic components and a cable 14 comprising a fiber bundle 16 and gas channels 18a and 18b for transporting gas to and from the interior of the housing 12.
  • a fiber terminator 20 directs light carried by the fiber bundle 16 toward a primary lens 22.
  • the light passed by the primary lens 22 is reflected by the dichroic mirror 24 toward a secondary mirror 26 which passes the light to a sapphire lens 28 contained in the tip of a conical housing 30.
  • the conical housing includes channels 32a and 32b for transporting cooling gas to the sapphire lens 28.
  • the sapphire lens 28 is placed in contact with the surface of the skin to be treated.
  • the sapphire lens will be cooled by CO 2 gas (or freon) flowing around the fiber tip and the lens 28 via the channels 18a, 18b and 32a, 32b, as shown in FIG. 7a.
  • the CO 2 may be replaced with freon if desired.
  • a viewing window 34 in the top of the housing can be used to observe the interaction of the radiation with the skin to monitor the progress of the treatment.
  • delivery device 210 comprises a housing 12 comprising a fiber bundle 16 as well as various optic components.
  • the fiber bundle 16 provides light energy or electromagnetic radiation to fiber terminator 20 which in turn directs the light carried by the fiber bundle 16 to a sapphire lens 28.
  • the sapphire lens 28 produces a collimated beam of light which is then applied to the skin as shown.
  • the delivery device 210 further includes gas flow ports 144a, 144b, 146a and 146b as shown.
  • the gas ports 144a and 144b receive a cooling gas which enters into the housing and then comes in contact with the sapphire lens 28 as shown. After making this contact, the gas then exits from the gas ports 146a and 146b as shown.
  • the embodiment of delivery device 212 shown in FIG. 8b is essentially similar except that the light carried by the fiber bundle 16 is passed through a first lens 152 and then to a second lens 154 which focuses the beam through a sapphire window 156 as shown onto the skin.
  • FIG. 8d illustrates the gas flow ports on the outside of the housing 12.
  • Gas ports 144a and 144b are shaded to reflect that gas flow is into the device, and gas ports 146a and 146b are unshaded to reflect that gas exits these ports.
  • the housing 12 may contain any number, i.e. more than four, gas flow ports.
  • FIG. 8c illustrates the gas flow pattern of the device 210.
  • the gas flow ports 144a and 144b receive gas from outside of the housing and direct this gas toward the sapphire lens 28. The gas comes in contact with the sapphire lens 28 and then passes outside one of the gas flow exit ports, for example, gas flow port 146a.
  • FIG. 9 shows a system wherein the components discussed above are used in connection with a computer to monitor and control the operation of the optical delivery system.
  • the light produced by an arc lamp 50 is focused by a reflector 52 and directed toward a "cold" mirror 54.
  • the cold mirror is a dichroic mirror which passes 90% of the infrared radiation produced by the arc lamp 50 and thus reflecting only approximately 10% of the infrared light.
  • a heat sink 56 absorbs the infrared fight passed by the cold mirror 54.
  • the light which is reflected by the cold mirror passes through a shutter 58 and a dichroic filter 60 to be received by a fiber optic terminator 62 secured to a mirror 64.
  • the filter 60 It is not necessary for the filter 60 to be capable of absorbing large amounts of infrared radiation, since the infrared has been effectively removed by passing through the cold mirror 54.
  • the light received by the terminator 62 is transmitted via fiber bundle 66 to the delivery system 10.
  • Light reflected by the skin is transmitted via cable 68 to a reflection monitoring system comprising a filter 70 and a detector 72, which produces an output signal corresponding to the intensity and wavelength of the reflected light.
  • the computer 74 which is used as the feedback controller, directly controls the shutter 58 between the light source and the fiber tip.
  • Output irradiance of the system may be controlled by using built-in tables stored in the computer memory for different irradiation parameters.
  • the specific surface temperature and irradiation parameters may also be preset by the operator through the computer 74.
  • FIGS. 14a and 14b illustrate the processing steps to control the system of the present invention.
  • step 100 the power to the lamp is initialized and in step 102 the temperature of the lamp is monitored.
  • step 104 a determination is made of whether the lamp is at the maximum temperature. If the lamp is at the maximum temperature, then the system is shut down in step 106. However, if the lamp is not at the maximum temperature, then a determination is made in step 108 of whether the lamp is at operating temperature. If the lamp is not at operating temperature, then the temperature is adjusted in step 110 and the system returns to step 102. However, if the lamp is at the operating temperature, then the system proceeds to step 112 where a determination is made of whether the foot pedal switch is activated.
  • step 118 the dose of radiation delivered to the skin is measured using two methods--time of delivery and reflection of radiation by the skin.
  • a decision is made of whether sufficient radiation has been delivered to the skin. If sufficient radiation has not been delivered, then the system continues to deliver radiation in step 122. However, if sufficient radiation has been delivered, then the pulse is turned off in step 124 and the shutter is closed in step 124.
  • step 128, a decision is made of whether the procedure is complete. If the procedure is not complete, the probe is moved to a new location and the system proceeds to step 108. However, if the procedure is complete, the system is powered down in step 132.
  • the surface cooling over a long period of time causes blood vessel reactions.
  • the small blood vessels i.e. less than 100-150 microns
  • the small blood vessels will be shut down if the cooling of the skin is continued for several minutes.
  • the blood vessels After prolonged cooling of the skin at temperatures below 15° C., the blood vessels enlarge. Previous data indicate a sudden change in blood flow as the blood vessel temperature is decreased below approximately 15° C.
  • the advantage of controlled epidermal surface cooling during irradiation is the lower temperature of the epidermis.
  • the main consideration in cooling the skin surface is the cooling rate which must be controlled for a near ideal treatment.
  • the curves for several cases from no-cooling up to a large convective cooling are shown in FIG. 10.
  • the curves due to surface cooling clearly indicate a much lower temperature at the surface than that of the non-cooling curve. Surface cooling may cause the maximum temperature to move away from the surface.
  • FIGS. 2 and 11 are the expected rate of heat generation as a function of depth in skin for wavelengths of 500 nm and 577 nm. These curves are based on one-dimensional diffusion theory and should represent the rate of heat generation at the center of a 3-5 mm spot. Considering both cases of FIG. 2 and FIG. 11, it may be concluded that the maximum depth to which the blood vessels are destroyed, at any wavelength, is the depth that the temperature of the blood vessels is equal to the temperature of epidermis. For example, the maximum depth that the dye laser may destroy the blood vessels at 577 nm case (FIG. 11 ) is approximately 0.6 mm whereas at the same depth the 500 nm wavelength does not produce as much temperature due to its lower blood absorption coefficient.
  • FIG. 12 is the maximum dermal depth as a function of wavelength where the heat production at the top of the blood vessel is larger than at the epidermal-dermal junction using Monte Carlo and Kubelka-Munk theories.
  • Different wavelengths from 525 to 585 nm may produce blood vessel coagulation in depths of interest; however, the wavelengths in the vicinity of 546 and 577 nm may be more suitable.
  • Irradiation containing the band of wavelengths around the 546 nm peak produces a higher epidermal temperature increase than an equal irradiance containing the band of wavelengths around 577 nm peak (for the case of the Arc lamp).
  • surface cooling will reduce the epidermal temperatures such that the epidermal temperature increase due to the wavelengths around the 546 peak becomes closer to that of the peak around 577 nm.
  • the two peaks of interest in the light source and their interaction is explained in the next section.
  • the temperature cooling system provided by the present invention is a pulsed cooling system with capability of dropping the skin surface temperature to 5° C. in about 100 milliseconds.
  • the computed temperature response of the skin for a fixed surface temperature of 5° C., and the onset of light irradiation after 100 ms is shown in FIG. 13. Blood vessels at a depth of 100 microns are cooled to 20° C. at the onset of light irradiation.
  • temperatures in the epidermis and upper dermis will be lower than the normal skin temperature.
  • the epidermal temperatures at the beginning of irradiation are lower than temperatures when cooling is omitted.
  • blood vessels are coagulated when temperatures reach 65° to 75° C.
  • peak temperatures at the epidermal-dermal junction are expected to be in the range of 40° to 50° C. Since rapid cooling of the skin creates lower blood vessel temperatures in the anterior vessels than the posterior vessels; the temperature of the vessels during light irradiation will be more uniform with depth than the present laser treatment.
  • sapphire or diamond are particularly suitable material for this application. They are transparent to visible light, allowing the laser beam to pass through and at the same time they possess high thermal conductivities (25 W/m °K and higher) or higher, allowing rapid transfer of heat which produces a lower temperature that advance to the front of the lens (and to the skin surface if the sapphire lens is touching the skin) while irradiation is being performed. Prior to the application, the skin surface must be exposed to saline or transparent ointments with high heat conductivity for better heat coupling efficiencies. The freon or CO 2 flow is controlled by a computer monitoring feedback system to keep the skin temperature at or above 5° C.
  • the system provided by the present invention offers numerous advantages over the prior art systems.
  • the estimated manufacturing cost of the proposed system is much lower than a laser dye system.
  • the lower manufacturing cost may reduce the treatment cost dramatically.
  • Another advantage of the proposed system is the ability to control the treatment by changing the rate of cooling, irradiation time and the spectrum of the irradiation light.
  • the maximum temperatures for the dermis and blood vessels can be adjusted by changing the treatment protocol.
  • the superficial blood vessels may be "shut down" by the rapid cooling; as a result, the cooling system may initially shut down the superficial blood vessels so that the light would coagulate the deeper vessels.
  • the proposed delivery system allows an increase in the total light energy delivered, so more abnormal blood vessels can be destroyed while preserving the epidermis and the epidermal-dermal junction. In other words, more lightening of the PWS lesion may be obtained with less risk of scarring.
  • the system will be easy to use and can be moved freely on the skin keeping the skin at the same relative distance from the lenses.

Abstract

An improved optical system for treatment of disorders of the skin, especially vascular lesions, such as Port Wine Stains. The system irradiates the skin with radiation at a predetermined wavelength and cools the skin during a predetermined time interval in coordination with delivery of the radiation. The absorption of the radiation by the skin and the change in temperature of the skin is monitored by the system and the operation of the radiation delivery system is controlled to optimize treatment of the vascular lesion. The source of irradiation is an arc lamp and the cooling system delivers a cooling gas to a lens in contact with the skin. The cooling gas can be carbon dioxide, freon, or any other appropriate gas. The lens used has a high heat conductivity and may be formed of sapphire.

Description

FIELD OF THE INVENTION
The present invention relates to an optical system for treatment of disorders of the skin, especially vascular lesions, such as Port Wine Stains.
BACKGROUND
PortWine Stains (PWS) are congenital disorders of the skin in which vascular malformations produce red-colored isolated lesions occurring most commonly on the face, trunk and neck. The lesion is basically an area of localized enlarged and ectatic blood vessels in the upper dermis. PWS tends to progress from a pale pink and flat lesions in childhood to nodular and dark red-purple lesions in adulthood. Its unpleasant cosmetic appearance causes psychological stress and makes the patient seek medical help. The goal of PWS treatment is to restore the normal color of the skin by selectively destroying the enlarged blood vessels while keeping the rest of the cutaneous structures intact.
The prior art method of choice for treatment of PWS is photocoagulation of the enlarged blood vessels. Ideally, absorption of the laser light by hemoglobin increases the temperature of the abnormal blood vessels until coagulation of blood and vessel walls takes place. Wavelengths for treatment of PWS are usually selected because of their high absorption by hemoglobin. The argon laser with lines at 488 and 514.4 nm has been selected for treatment of PWS because of its high absorption in blood. Recently better coupling has been achieved by matching a pulse dye laser to the 577 nm peak of oxygenated hemoglobin. However, coagulation of the enlarged vessels has been demonstrated at other wavelengths such as 1.06 and 10.6 μm.
Ideally, laser treatment should selectively destroy dermal blood vessels up to a depth of approximately 0.6 mm without causing damage to the epidermis, and especially to the epidermal-dermal layer since damage to this layer disturbs the healing process and may lead to scarring. Epidermal melanin, however, is also an important chromophore with strong absorption in the ultraviolet that decreases through the visible spectrum. Melanin, therefore, has been a potential barrier for the incident laser light causing hearing of the epidermis and reducing the amount of light which reaches the underlying blood vessels.
One of the most recent lasers for the treatment of PortWine Stain is the pulsed dye laser tuned to 577 nm, which is at one of the high absorption peaks of hemoglobin. At 577 nm absorption by epidermal melanin and scattering by the dermis is lower than at the 540 nm peak or at argon wavelengths. The rate of heat generation is higher in the blood vessels than in the epidermis. Although pulse durations of 1 μs or less cause microvascular hemorrhage, 360 μs pulses seem to be very effective in causing selective vascular damage without excessive damage to the epidermis or non-vascular dermal structure. Although investigators report no scarring or any apparent epidermal damage after treatment of PWS lesions with 360 μs pulse 577 nm dye laser, at a dose of 6.5 to 10 J/cm2, only an overall lightening of 42% has been obtained in the PWS lesions after the initial treatment, and retreatment sessions improved the overall lightening to 68%. Higher energy doses per treatment may produce unwanted epidermal or dermal damage.
A pulsed dye laser system is expensive for an average Dermatologist with a limited purchasing power. However, in the treatment of vascular lesions the coherence of the laser beam is not a critical consideration as long as a light source with proper powers at the right wavelengths can be focused onto the skin with spot sizes in the range of 3-5 mm in diameter (similar to the spot sizes reported in such applications).
The tunable dye laser based systems have been very effective in exploring the mechanisms of the PWS treatments. At the present, the purchasing cost of such laser based systems is approximately $150,000 and the annual maintenance is estimated to be $25,000 per laser system. Consequently, most Dermatologists can not justify the high cost of purchasing a laser based systems for this application. Another cost consideration is the patients who may not be able to afford the high costs of such treatments. Therefore, there is a need for a low-cost system to achieve the same treatment for a much lower cost than the present treatment cost. Such a system is provided by the present invention, described in greater detail below.
SUMMARY OF THE INVENTION
The present invention provides an improved optical system for treatment of disorders of the skin, especially vascular lesions, such as PortWine Stains. In the preferred embodiment of the present invention the system comprises means for irradiating the skin with radiation at a predetermined wavelength. The system also comprises means for cooling the skin during a predetermined time interval in coordination with delivery of the radiation. The absorption of the radiation by the skin and the change in temperature of the skin is monitored by the system and the operation of the radiation delivery system is controlled to optimize treatment of the vascular lesion. In the preferred embodiment of the invention, the source of irradiation is an arc lamp. The means for cooling comprises a system for delivering a cooling gas to a lens in contact with the skin. The cooling gas can be carbon dioxide, freon, or any other appropriate gas. The lens used in the preferred embodiment is formed of sapphire.
BRIEF DESCRIPTION OF THE DRAWINGS
Further advantages and a more complete understanding of the invention can be obtained by referring to the following detailed description of specific embodiments when taken in conjunction with the accompanying drawings in which:
FIG. 1 is an illustration of a blood vessel in relation to the dermis and epidermis.
FIG. 2 is a graphical illustration of the volumetric heat generated in skin as a function of depth for 500 nm light.
FIG. 3 is a graphical illustration of the absorption of light produce by an arc lamp by blood.
FIG. 4 is a graphical illustration of the spectral emission of a Mercury-Xenon arc lamp.
FIG. 5 is a graphical illustration the rate of heat generation as a function of wavelength of irradiation for blood, dermis and epidermis.
FIG. 6 is a graphical illustration of skin absorption and scattering characteristics.
FIGS. 7a-7b is an illustration of the preferred embodiment of the system for delivering radiation to the skin in accordance with the present invention.
FIGS. 8a-8d is an illustration of alternate embodiments of the system for delivering radiation to the skin in accordance with the present invention.
FIG. 9 is an illustration of a computer based control system for controlling the rate of irradiation of the treatment area.
FIG. 10 is a graphical illustration of the effects of cooling on skin.
FIG. 11 is a graphical illustration of volumetric heat generated in skin as a function of depth for irradiation at 577 nm.
FIG. 12 is the maximum dermal depth as a function of wavelength where the heat production at the top of the blood vessel is larger than at the epidermal-dermal junction using Monte Carlo and Kubelka-Munk theories.
FIG. 13 is a graphical illustration of skin temperature as a function of depth for cooling at various rates.
FIGS. 14a-14b are flow charts of the control and processing steps implemented in the system of the present invention.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
Optically, the skin can be represented by two layers: a thin absorbing layer (epidermis) and predominantly scattering layer (dermis), as shown in FIG. 1. The enlarged blood vessels in PWS are located mainly at a distance of 0.3 to 0.6 mm from the epidermal-dermal junction. Blood vessels are typically modeled as either a thin absorbing layer or as individual cylinders or spheres. The goal of PWS treatment is to restore the normal color of the skin by selectively destroying the enlarged blood vessels while keeping the rest of the cutaneous structures intact.
The rate of heat generation S[W/cm3 ] in the tissue due to absorption of radiation is:
S(z)=μ.sub.a(z) φ(z)
where μa is the local absorption coefficient and φ(z) is the fluence rate. The rate of heat generation at 500 nm is shown in FIG. 2.
The wavelength spectrum of lasers presently used for PWS treatment vary from 488 nm up to 590 nm with the optimum treatment at 585 nm. FIG. 3, which is the blood absorption characteristic as a function of wavelength, reveals that the absorption of blood (HbO and Hb) is not sharp in a small neighborhood of the selected laser wavelengths. The advantage of using a dye laser at 585 nm appears to be the higher penetration depths with minimal epidermal heating and scarring. It has been suggested that an argon laser would perform better if the heat could be removed from the surface.
The light source employed in the present invention is a "Mercury Vapor Arc lamp" with a wavelength characteristic shown in FIG. 4. However, other light sources may be utilized, such as a xenon arc lamp. Arc lamp power ratings up to 10,000 watts are commercially available. However, an Arc lamp with a power rating of 2500 watts would produce sufficient light intensity for vascular lesion treatments. An important characteristic of the lamp is that it produces two narrow linewidths of light about the peaks of 546 and 579 nm, which coincide with blood absorption peaks at 540 and 577 nm. The lamp spectral distribution with respect to the blood absorption spectrum is shown in FIG. 3. The Full Width Half Maximum (FWHM) of the lamp peak at 579 is 10 nm and at 546 is 6 nm.
If the entire band of wavelengths from 530 to 560 nm is used (using the Arc lamp) then the epidermal temperature may exceed the temperature of blood vessels deeper than 0.28 mm. Consequently, the present invention includes a temperature compensation and monitoring system, discussed in greater detail below, to reduce the epidermal and dermal temperatures such that the overall system produces, in the epidermis and dermis, temperatures at least as low as the dye lasers at 577 or 585 nm.
EFFECT OF NARROW-BAND ARC LAMP ON SKIN
FIG. 3 is the blood absorption coefficient in the range of 450-600 nm with the corresponding characteristic of the Arc lamp spectrum. The resultant rate of heat generation in blood, epidermis and dermis are shown in FIG. 5.
The difference in the rate of heat generation in the epidermis and dermis for Arc lamp irradiation will result in higher temperatures as compared to the dye laser at 577 and 585 nm at equal irradiance. Since the epidermal heat generation is approximately 3.5 times that of dermis, the dermis will always be at lower temperatures than epidermis. As a result, the temperature of epidermis must be lowered during the Arc lamp irradiation to remove the excess heat generated. The worst case heating of the epidermis is the case of using only 500 nm irradiation. The absorption coefficients at 500 nm, using FIG. 6, are: Ab =140 and Ae =38, Ad =12 cm-1. Therefore, the expected temperature in epidermis is 1.72 times more than the case for the dye lasers at 577 and 585 nm (1.36 times higher irradiance @ 1.26 times higher absorption).
The epidermal temperature increase using a dye laser is assumed to be approximately 20° C. In order to achieve an equivalent blood vessel coagulation at 0.6 mm depths using 500 nm, the epidermis temperature must be brought down approximately 15° C. below the normal skin temperature, before irradiation. This is the worst case situation in using the Arc lamp. The system of the present invention is capable of cooling the skin to temperatures as low as 5° C., which is more than the cooling capability needed for this treatment.
The system show in FIGS. 7a-7b and the alternate embodiment shown in FIGS. 8a-8d is used to deliver light energy to skin while controlling the amount of radiation delivered. Referring to FIG. 7a, the delivery device 10 comprises a housing 12 containing optic components and a cable 14 comprising a fiber bundle 16 and gas channels 18a and 18b for transporting gas to and from the interior of the housing 12. A fiber terminator 20 directs light carried by the fiber bundle 16 toward a primary lens 22. The light passed by the primary lens 22 is reflected by the dichroic mirror 24 toward a secondary mirror 26 which passes the light to a sapphire lens 28 contained in the tip of a conical housing 30. The conical housing includes channels 32a and 32b for transporting cooling gas to the sapphire lens 28. The sapphire lens 28 is placed in contact with the surface of the skin to be treated. The sapphire lens will be cooled by CO2 gas (or freon) flowing around the fiber tip and the lens 28 via the channels 18a, 18b and 32a, 32b, as shown in FIG. 7a. The CO2 may be replaced with freon if desired. A viewing window 34 in the top of the housing can be used to observe the interaction of the radiation with the skin to monitor the progress of the treatment.
Referring now to FIGS. 8a-8d, an alternate embodiment of the invention is shown. Elements that are identical to the elements appearing in FIGS. 7a-7b are designated with the same reference numbers for simplicity. As shown in FIG. 8a, delivery device 210 comprises a housing 12 comprising a fiber bundle 16 as well as various optic components. The fiber bundle 16 provides light energy or electromagnetic radiation to fiber terminator 20 which in turn directs the light carried by the fiber bundle 16 to a sapphire lens 28. The sapphire lens 28 produces a collimated beam of light which is then applied to the skin as shown. The delivery device 210 further includes gas flow ports 144a, 144b, 146a and 146b as shown. The gas ports 144a and 144b receive a cooling gas which enters into the housing and then comes in contact with the sapphire lens 28 as shown. After making this contact, the gas then exits from the gas ports 146a and 146b as shown.
The embodiment of delivery device 212 shown in FIG. 8b is essentially similar except that the light carried by the fiber bundle 16 is passed through a first lens 152 and then to a second lens 154 which focuses the beam through a sapphire window 156 as shown onto the skin.
FIG. 8d illustrates the gas flow ports on the outside of the housing 12. Gas ports 144a and 144b are shaded to reflect that gas flow is into the device, and gas ports 146a and 146b are unshaded to reflect that gas exits these ports. As shown in FIG. 8d, the housing 12 may contain any number, i.e. more than four, gas flow ports.
FIG. 8c illustrates the gas flow pattern of the device 210. As shown, the gas flow ports 144a and 144b receive gas from outside of the housing and direct this gas toward the sapphire lens 28. The gas comes in contact with the sapphire lens 28 and then passes outside one of the gas flow exit ports, for example, gas flow port 146a.
FIG. 9 shows a system wherein the components discussed above are used in connection with a computer to monitor and control the operation of the optical delivery system. The light produced by an arc lamp 50 is focused by a reflector 52 and directed toward a "cold" mirror 54. The cold mirror is a dichroic mirror which passes 90% of the infrared radiation produced by the arc lamp 50 and thus reflecting only approximately 10% of the infrared light. A heat sink 56 absorbs the infrared fight passed by the cold mirror 54. The light which is reflected by the cold mirror passes through a shutter 58 and a dichroic filter 60 to be received by a fiber optic terminator 62 secured to a mirror 64. It is not necessary for the filter 60 to be capable of absorbing large amounts of infrared radiation, since the infrared has been effectively removed by passing through the cold mirror 54. The light received by the terminator 62 is transmitted via fiber bundle 66 to the delivery system 10. Light reflected by the skin is transmitted via cable 68 to a reflection monitoring system comprising a filter 70 and a detector 72, which produces an output signal corresponding to the intensity and wavelength of the reflected light. The computer 74 which is used as the feedback controller, directly controls the shutter 58 between the light source and the fiber tip. Output irradiance of the system may be controlled by using built-in tables stored in the computer memory for different irradiation parameters. The specific surface temperature and irradiation parameters may also be preset by the operator through the computer 74.
FIGS. 14a and 14b illustrate the processing steps to control the system of the present invention. In step 100 the power to the lamp is initialized and in step 102 the temperature of the lamp is monitored. In step 104, a determination is made of whether the lamp is at the maximum temperature. If the lamp is at the maximum temperature, then the system is shut down in step 106. However, if the lamp is not at the maximum temperature, then a determination is made in step 108 of whether the lamp is at operating temperature. If the lamp is not at operating temperature, then the temperature is adjusted in step 110 and the system returns to step 102. However, if the lamp is at the operating temperature, then the system proceeds to step 112 where a determination is made of whether the foot pedal switch is activated. If the foot pedal is not activated, the system returns to step 108. However, if the foot pedal is activated, the cooling system is activated in step 114 and the power supply is pulsed in step 116. In step 118, the dose of radiation delivered to the skin is measured using two methods--time of delivery and reflection of radiation by the skin. In step 120 a decision is made of whether sufficient radiation has been delivered to the skin. If sufficient radiation has not been delivered, then the system continues to deliver radiation in step 122. However, if sufficient radiation has been delivered, then the pulse is turned off in step 124 and the shutter is closed in step 124. In step 128, a decision is made of whether the procedure is complete. If the procedure is not complete, the probe is moved to a new location and the system proceeds to step 108. However, if the procedure is complete, the system is powered down in step 132.
SURFACE COOLING DURING LIGHT IRRADIATION
Prior investigators have reported that cooling the skin with ice packs prior to treatment of PortWine Stains with argon laser radiation decreased the incidence of scarring. Other investigators, using Neodymium-YAG laser, also reported reduced damage to the epidermis by skin-cooling techniques using direct spraying of freon during laser irradiation. Other reports further suggest that varying skin temperature has an effect on the dose required to produce purpura in human skin with a pulse tunable dye laser.
The surface cooling over a long period of time (i.e. hundreds of seconds) causes blood vessel reactions. The small blood vessels (i.e. less than 100-150 microns) will be shut down if the cooling of the skin is continued for several minutes. After prolonged cooling of the skin at temperatures below 15° C., the blood vessels enlarge. Previous data indicate a sudden change in blood flow as the blood vessel temperature is decreased below approximately 15° C.
The advantage of controlled epidermal surface cooling during irradiation is the lower temperature of the epidermis. The main consideration in cooling the skin surface is the cooling rate which must be controlled for a near ideal treatment. The surface cooling effect for the case of a simple thick medium (with tissue parameters, i.e. Absorption=23 cm-1, Scattering=10 cm-1) irradiated with 2 W, 2 mm Argon laser beam for 250 millisecond, has been simulated on a computer and the results are shown in FIG. 10. The curves for several cases from no-cooling up to a large convective cooling are shown in FIG. 10. The curves due to surface cooling clearly indicate a much lower temperature at the surface than that of the non-cooling curve. Surface cooling may cause the maximum temperature to move away from the surface.
FIGS. 2 and 11 are the expected rate of heat generation as a function of depth in skin for wavelengths of 500 nm and 577 nm. These curves are based on one-dimensional diffusion theory and should represent the rate of heat generation at the center of a 3-5 mm spot. Considering both cases of FIG. 2 and FIG. 11, it may be concluded that the maximum depth to which the blood vessels are destroyed, at any wavelength, is the depth that the temperature of the blood vessels is equal to the temperature of epidermis. For example, the maximum depth that the dye laser may destroy the blood vessels at 577 nm case (FIG. 11 ) is approximately 0.6 mm whereas at the same depth the 500 nm wavelength does not produce as much temperature due to its lower blood absorption coefficient.
FIG. 12 is the maximum dermal depth as a function of wavelength where the heat production at the top of the blood vessel is larger than at the epidermal-dermal junction using Monte Carlo and Kubelka-Munk theories. Different wavelengths from 525 to 585 nm may produce blood vessel coagulation in depths of interest; however, the wavelengths in the vicinity of 546 and 577 nm may be more suitable. Irradiation containing the band of wavelengths around the 546 nm peak produces a higher epidermal temperature increase than an equal irradiance containing the band of wavelengths around 577 nm peak (for the case of the Arc lamp). However, surface cooling will reduce the epidermal temperatures such that the epidermal temperature increase due to the wavelengths around the 546 peak becomes closer to that of the peak around 577 nm. The two peaks of interest in the light source and their interaction is explained in the next section.
SYSTEM FOR CONTROL OF SKIN TEMPERATURE
The temperature cooling system provided by the present invention is a pulsed cooling system with capability of dropping the skin surface temperature to 5° C. in about 100 milliseconds. The computed temperature response of the skin for a fixed surface temperature of 5° C., and the onset of light irradiation after 100 ms is shown in FIG. 13. Blood vessels at a depth of 100 microns are cooled to 20° C. at the onset of light irradiation.
As the surface temperature of the skin is rapidly cooled to approximately 5° C., temperatures in the epidermis and upper dermis will be lower than the normal skin temperature. The epidermal temperatures at the beginning of irradiation are lower than temperatures when cooling is omitted. At the end of an irradiation pulse of 10-50 milliseconds, blood vessels are coagulated when temperatures reach 65° to 75° C. With surface cooling corresponding peak temperatures at the epidermal-dermal junction are expected to be in the range of 40° to 50° C. Since rapid cooling of the skin creates lower blood vessel temperatures in the anterior vessels than the posterior vessels; the temperature of the vessels during light irradiation will be more uniform with depth than the present laser treatment.
Due to its thermal properties, sapphire or diamond are particularly suitable material for this application. They are transparent to visible light, allowing the laser beam to pass through and at the same time they possess high thermal conductivities (25 W/m °K and higher) or higher, allowing rapid transfer of heat which produces a lower temperature that advance to the front of the lens (and to the skin surface if the sapphire lens is touching the skin) while irradiation is being performed. Prior to the application, the skin surface must be exposed to saline or transparent ointments with high heat conductivity for better heat coupling efficiencies. The freon or CO2 flow is controlled by a computer monitoring feedback system to keep the skin temperature at or above 5° C.
The system provided by the present invention offers numerous advantages over the prior art systems. The estimated manufacturing cost of the proposed system is much lower than a laser dye system. The lower manufacturing cost may reduce the treatment cost dramatically.
Another advantage of the proposed system is the ability to control the treatment by changing the rate of cooling, irradiation time and the spectrum of the irradiation light. The maximum temperatures for the dermis and blood vessels can be adjusted by changing the treatment protocol.
The superficial blood vessels may be "shut down" by the rapid cooling; as a result, the cooling system may initially shut down the superficial blood vessels so that the light would coagulate the deeper vessels. The proposed delivery system allows an increase in the total light energy delivered, so more abnormal blood vessels can be destroyed while preserving the epidermis and the epidermal-dermal junction. In other words, more lightening of the PWS lesion may be obtained with less risk of scarring.
The system will be easy to use and can be moved freely on the skin keeping the skin at the same relative distance from the lenses.
Presently used lasers are not power efficient. The efficiency of some lasers used in this application may be as low as 0.01%. The Arc lamp is a much more efficient system. Total light generation capability of the Arc lamp is in the order of 40-60%. In this application only 9% of the light is used for the treatment which makes this system more efficient than the dye lasers. A reasonably sized portable system may be feasible if there is a need for such device. Finally, due to the large area cooling system, the pain may be reduced.
While the foregoing discussion of the invention contains many specificities, these should not be construed as limiting the scope of the invention, but rather as merely providing illustrations of exemplary embodiments of the invention. Many other variations and modifications of the invention will be apparent to those of skill in the art without departing from the spirit and the scope of the invention as defined by the appended claims and their equivalents.

Claims (13)

What is claimed is:
1. An optical system for treating vascular lesions, comprising:
irradiating means for irradiating skin with electromagnetic radiation;
monitoring means coupled to said irradiating means for monitoring absorption of said radiation by said skin;
controlling means coupled to said monitoring means and said irradiating means for controlling the operation of said irradiating means to deliver a predetermined dose of radiation to said skin; and
cooling means coupled to said irradiating means for cooling the surface of said skin, said cooling means comprising:
a lens having one side in contact with said skin, wherein said lens is comprised of a material that is transparent to visible light and has a high thermal conductivity; and
means for circulating a cooling .[.gas.]. .Iadd.medium .Iaddend.to contact with said lens on the side not in contact with said skin.
2. The system of claim 1, wherein said irradiating means comprises an arc lamp.
3. The system of claim 2, wherein said monitoring means comprises means for measuring the time of .[.absorption.]. .Iadd.delivery .Iaddend.of radiation.
4. The system of claim 2, wherein said monitoring means comprises means for measuring the reflection of radiation from the skin.
5. The system of claim 1, wherein said cooling .[.gas.]. .Iadd.medium .Iaddend.comprises freon.
6. The system of claim 1, wherein said cooling .[.gas.]. .Iadd.medium .Iaddend.comprises carbon dioxide.
7. The system of claim 1, wherein said lens material is sapphire.
8. The system of claim 1, wherein said lens material is diamond. .Iadd.
9. A method of treatment with light energy comprising the steps of:
providing a pulsed light output having a spectrum of frequencies continuous over at least one bandwidth from a non-laser, incoherent light source; and
directing said pulsed light output to skin, said pulsed light having controllable irradiation parameters to produce a controlled peak temperature at a variable controlled depth below a surface of said skin to selectively coagulate a target in said skin. .Iaddend..Iadd.10. A method of treating skin, comprising the steps of:
cooling a surface of skin to a predetermined temperature; and
irradiating said skin with electromagnetic radiation, at a predetermined time relative to initiation of said step of cooling said skin to produce a controlled peak temperature at a variable controlled depth. .Iaddend..Iadd.11. The method according to claim 10, said step of irradiating said skin with electromagnetic radiation further comprising the step of controlling a source of electromagnetic radiation to provide
pulses of electromagnetic radiation. .Iaddend..Iadd.12. An apparatus for treating skin, comprising:
pulsed cooling means operable to cool a surface of skin to a predetermined temperature; and
a source of electromagnetic radiation for irradiating said skin with electromagnetic radiation at a predetermined time relative to pulses of said pulsed cooling said skin to produce a controlled peak temperature at a variable controlled depth below a surface of said skin. .Iaddend..Iadd.13. The apparatus according to claim 12, said source of electromagnetic radiation being operable to provide pulses of
electromagnetic radiation. .Iaddend..Iadd.14. The apparatus of claim 12, wherein said predetermined time is subsequent to the cooling of said skin.
.Iaddend..Iadd.15. A method of treating skin, comprising the steps of:
heating a portion of skin;
cooling the surface of said skin; and
controlling said heating and cooling steps of establish a controlled temperature at said skin surface and a controlled peak temperature at a
variable controlled depth below said surface. .Iaddend..Iadd.16. The method according to claim 15, wherein said cooling step comprises contacting said skin with a cooled lens comprising a material with a high thermal conductivity. .Iaddend..Iadd.17. The method of claim 16, said lens comprising sapphire. .Iaddend.
US08/711,685 1991-12-12 1996-09-05 Optical system for treatment of vascular lesions Expired - Fee Related USRE36634E (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US08/711,685 USRE36634E (en) 1991-12-12 1996-09-05 Optical system for treatment of vascular lesions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/807,055 US5344418A (en) 1991-12-12 1991-12-12 Optical system for treatment of vascular lesions
US08/711,685 USRE36634E (en) 1991-12-12 1996-09-05 Optical system for treatment of vascular lesions

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US07/807,055 Reissue US5344418A (en) 1991-12-12 1991-12-12 Optical system for treatment of vascular lesions

Publications (1)

Publication Number Publication Date
USRE36634E true USRE36634E (en) 2000-03-28

Family

ID=25195456

Family Applications (2)

Application Number Title Priority Date Filing Date
US07/807,055 Ceased US5344418A (en) 1991-12-12 1991-12-12 Optical system for treatment of vascular lesions
US08/711,685 Expired - Fee Related USRE36634E (en) 1991-12-12 1996-09-05 Optical system for treatment of vascular lesions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US07/807,055 Ceased US5344418A (en) 1991-12-12 1991-12-12 Optical system for treatment of vascular lesions

Country Status (1)

Country Link
US (2) US5344418A (en)

Cited By (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6273885B1 (en) * 1997-08-16 2001-08-14 Cooltouch Corporation Handheld photoepilation device and method
US6436094B1 (en) * 2000-03-16 2002-08-20 Laserscope, Inc. Electromagnetic and laser treatment and cooling device
US6508813B1 (en) 1996-12-02 2003-01-21 Palomar Medical Technologies, Inc. System for electromagnetic radiation dermatology and head for use therewith
US6511475B1 (en) 1997-05-15 2003-01-28 The General Hospital Corporation Heads for dermatology treatment
US6517532B1 (en) 1997-05-15 2003-02-11 Palomar Medical Technologies, Inc. Light energy delivery head
US20030069567A1 (en) * 1992-10-20 2003-04-10 Shimon Eckhouse Method and apparatus for electromagnetic treatment of the skin, including hair depilation
US20030109860A1 (en) * 2001-12-12 2003-06-12 Michael Black Multiple laser treatment
US6605080B1 (en) 1998-03-27 2003-08-12 The General Hospital Corporation Method and apparatus for the selective targeting of lipid-rich tissues
US20030212393A1 (en) * 1996-01-05 2003-11-13 Knowlton Edward W. Handpiece with RF electrode and non-volatile memory
US6653618B2 (en) 2000-04-28 2003-11-25 Palomar Medical Technologies, Inc. Contact detecting method and apparatus for an optical radiation handpiece
US20030233138A1 (en) * 2002-06-12 2003-12-18 Altus Medical, Inc. Concentration of divergent light from light emitting diodes into therapeutic light energy
US20040000316A1 (en) * 1996-01-05 2004-01-01 Knowlton Edward W. Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient
US20040002704A1 (en) * 1996-01-05 2004-01-01 Knowlton Edward W. Treatment apparatus with electromagnetic energy delivery device and non-volatile memory
US6682524B1 (en) * 1998-11-12 2004-01-27 Asclepion Laser Technologies Gmbh Dermatological hand piece
US20040030332A1 (en) * 1996-01-05 2004-02-12 Knowlton Edward W. Handpiece with electrode and non-volatile memory
US20040034319A1 (en) * 2002-03-12 2004-02-19 Palomar Medical Technologies, Inc. Method and apparatus for hair growth management
US20040034346A1 (en) * 1996-01-05 2004-02-19 Stern Roger A. RF device with thermo-electric cooler
US20040073079A1 (en) * 2002-06-19 2004-04-15 Palomar Medical Technologies, Inc. Method and apparatus for treatment of cutaneous and subcutaneous conditions
US6723090B2 (en) 2001-07-02 2004-04-20 Palomar Medical Technologies, Inc. Fiber laser device for medical/cosmetic procedures
US20040082940A1 (en) * 2002-10-22 2004-04-29 Michael Black Dermatological apparatus and method
US20040116984A1 (en) * 2002-12-12 2004-06-17 Greg Spooner Method and system for controlled spatially-selective epidermal pigmentation phototherapy with UVA LEDs
US20040147984A1 (en) * 2001-11-29 2004-07-29 Palomar Medical Technologies, Inc. Methods and apparatus for delivering low power optical treatments
US20040162549A1 (en) * 2002-11-12 2004-08-19 Palomar Medical Technologies, Inc. Method and apparatus for performing optical dermatology
US20040167500A1 (en) * 2003-02-25 2004-08-26 Weckwerth Mark V. Self-contained, diode-laser-based dermatologic treatment apparatus and method
US20040260367A1 (en) * 2001-12-21 2004-12-23 Luis De Taboada Device and method for providing phototherapy to the heart
US20050015124A1 (en) * 2000-10-20 2005-01-20 Irwin Dean S. Treatment of skin disorders with UV light and cooling
US20050049582A1 (en) * 2001-12-12 2005-03-03 Debenedictis Leonard C. Method and apparatus for fractional photo therapy of skin
US20050107851A1 (en) * 2002-11-01 2005-05-19 Taboada Luis D. Device and method for providing phototherapy to the brain
US20050137658A1 (en) * 2003-12-17 2005-06-23 Hennings David R. Treatment of superficial pigmented and vascular lesions of the skin
US20050141068A1 (en) * 2003-12-31 2005-06-30 Debenedictis Leonard C. High speed, high efficiency optical pattern generator using rotating optical elements
US20050143719A1 (en) * 2003-12-31 2005-06-30 Sink Robert K. Multi-spot laser surgical apparatus and method
US20050177208A1 (en) * 2001-10-18 2005-08-11 Irwin Dean S. Device for oral UV photo-therapy
US20050203491A1 (en) * 2000-09-12 2005-09-15 Khomchenko Vladimir V. Method of laser coagulation of blood vessels
US20050215988A1 (en) * 2000-01-25 2005-09-29 Palomar Medical Technologies, Inc. Method and apparatus for medical treatment utilizing long duration electromagnetic radiation
US20050259306A1 (en) * 2003-12-31 2005-11-24 Broome Barry G Two-dimensional optical scan system using a counter-rotating disk scanner
US20050278002A1 (en) * 2004-06-14 2005-12-15 David Eimerl Adaptive control of optical pulses for laser medicine
US20060004306A1 (en) * 2004-04-09 2006-01-05 Palomar Medical Technologies, Inc. Methods and products for producing lattices of EMR-treated islets in tissues, and uses therefor
US20060009750A1 (en) * 2001-03-02 2006-01-12 Palomar Medical Technologies, Inc. Apparatus and method for treatment using a patterned mask
US6997923B2 (en) 2000-12-28 2006-02-14 Palomar Medical Technologies, Inc. Method and apparatus for EMR treatment
US20060111760A1 (en) * 2001-08-10 2006-05-25 Lajos Kemeny Phototherapeutical method and system for the treatment of inflammatory and hyperproliferative disorders of the nasal mucosa
US20060155266A1 (en) * 2003-03-27 2006-07-13 Dieter Manstein Method and apparatus for dermatological treatment and fractional skin resurfacing
US7083610B1 (en) * 2000-06-07 2006-08-01 Laserscope Device for irradiating tissue
US20060197247A1 (en) * 1998-02-12 2006-09-07 Moldflow Pty Ltd Automated Molding Technology For Thermoplastic Injection Molding
US20060206103A1 (en) * 2001-03-02 2006-09-14 Palomar Medical Technologies, Inc. Dermatological treatment device
US20060253176A1 (en) * 2005-02-18 2006-11-09 Palomar Medical Technologies, Inc. Dermatological treatment device with deflector optic
US7147654B2 (en) 2003-01-24 2006-12-12 Laserscope Treatment Site Cooling System of Skin Disorders
US20070010811A1 (en) * 1999-03-09 2007-01-11 Thermage, Inc. energy delivery device for treating tissue
US20070038206A1 (en) * 2004-12-09 2007-02-15 Palomar Medical Technologies, Inc. Photocosmetic device
US20070067006A1 (en) * 2002-05-23 2007-03-22 Palomar Medical Technologies, Inc. Phototreatment device for use with coolants
US20070129711A1 (en) * 1999-01-08 2007-06-07 Altshuler Gregory B Cooling system for a photocosmetic device
US7250045B2 (en) 2003-02-25 2007-07-31 Spectragenics, Inc. Self-contained, eye-safe hair-regrowth-inhibition apparatus and method
US20070194717A1 (en) * 2006-02-17 2007-08-23 Palomar Medical Technologies, Inc. Lamp for use in a tissue treatment device
US20070219604A1 (en) * 2006-03-20 2007-09-20 Palomar Medical Technologies, Inc. Treatment of tissue with radiant energy
US7282060B2 (en) 2003-12-23 2007-10-16 Reliant Technologies, Inc. Method and apparatus for monitoring and controlling laser-induced tissue treatment
US20070255274A1 (en) * 1996-01-05 2007-11-01 Thermage, Inc. Method and kit for treatment of tissue
US20070255355A1 (en) * 2006-04-06 2007-11-01 Palomar Medical Technologies, Inc. Apparatus and method for skin treatment with compression and decompression
US20080033413A1 (en) * 2001-03-01 2008-02-07 Palomar Medical Technologies, Inc. Flashlamp drive circuit
US7372606B2 (en) 2003-12-31 2008-05-13 Reliant Technologies, Inc. Optical pattern generator using a single rotating component
US20080139901A1 (en) * 1996-12-02 2008-06-12 Palomar Medical Technologies, Inc. Cooling System For A Photocosmetic Device
US20080161745A1 (en) * 2006-09-08 2008-07-03 Oliver Stumpp Bleaching of contrast enhancing agent applied to skin for use with a dermatological treatment system
US20080161782A1 (en) * 2006-10-26 2008-07-03 Reliant Technologies, Inc. Micropore delivery of active substances
US20080183162A1 (en) * 2000-12-28 2008-07-31 Palomar Medical Technologies, Inc. Methods And Devices For Fractional Ablation Of Tissue
US20080186591A1 (en) * 2007-02-01 2008-08-07 Palomar Medical Technologies, Inc. Dermatological device having a zoom lens system
US7413567B2 (en) 2003-02-25 2008-08-19 Spectragenics, Inc. Optical sensor and method for identifying the presence of skin
US7452356B2 (en) 2003-02-25 2008-11-18 Tria Beauty, Inc. Eye-safe dermatologic treatment apparatus
US20090043294A1 (en) * 2003-02-25 2009-02-12 Spectragenics, Inc. Capacitive Sensing Method and Device for Detecting Skin
US20090054879A1 (en) * 2007-08-23 2009-02-26 Ntk Enterprises, Inc. System and method for defining and controlling ltk and other surgical eye procedures to produce little or no stromal collagen shrinkage
US20090125006A1 (en) * 2004-02-25 2009-05-14 Spectragenics, Inc. Optical Sensor and Method for Identifying the Presence of Skin
US20090204109A1 (en) * 2003-02-25 2009-08-13 Tria Beauty, Inc. Eye-Safe Dermatologic Treatment Apparatus and Method
US20090270848A1 (en) * 2008-04-25 2009-10-29 Tria Beauty, Inc. Optical Sensor and Method for Identifying the Presence of Skin and the Pigmentation of Skin
US20100069898A1 (en) * 2003-02-25 2010-03-18 Tria Beauty, Inc. Acne Treatment Method, System and Device
US7691099B2 (en) 2006-07-12 2010-04-06 Ntk Enterprises, Inc. Deuterated ocular solutions for LTK and other surgical eye procedures
US20100204686A1 (en) * 2002-12-20 2010-08-12 Palomar Medical Technologies, Inc. Light treatments for acne and other disorders of follicles
US7981111B2 (en) 2003-02-25 2011-07-19 Tria Beauty, Inc. Method and apparatus for the treatment of benign pigmented lesions
USRE42594E1 (en) 1998-10-16 2011-08-02 Reliant Technologies, Inc. Tissue cooling rod for laser surgery
US8268332B2 (en) 2004-04-01 2012-09-18 The General Hospital Corporation Method for dermatological treatment using chromophores
US8346347B2 (en) 2005-09-15 2013-01-01 Palomar Medical Technologies, Inc. Skin optical characterization device
US9028536B2 (en) 2006-08-02 2015-05-12 Cynosure, Inc. Picosecond laser apparatus and methods for its operation and use
US9113934B2 (en) 2011-05-16 2015-08-25 Covidien Lp Optical energy-based methods and apparatus for tissue sealing
US9113900B2 (en) 1998-10-23 2015-08-25 Covidien Ag Method and system for controlling output of RF medical generator
US9780518B2 (en) 2012-04-18 2017-10-03 Cynosure, Inc. Picosecond laser apparatus and methods for treating target tissues with same
US9833285B2 (en) 2012-07-17 2017-12-05 Covidien Lp Optical sealing device with cutting ability
US9919168B2 (en) 2009-07-23 2018-03-20 Palomar Medical Technologies, Inc. Method for improvement of cellulite appearance
US10245107B2 (en) 2013-03-15 2019-04-02 Cynosure, Inc. Picosecond optical radiation systems and methods of use
US10434324B2 (en) 2005-04-22 2019-10-08 Cynosure, Llc Methods and systems for laser treatment using non-uniform output beam
US10799292B2 (en) 2018-05-04 2020-10-13 Bin Rao High power tunable optical parametric oscillator for selective photothermolysis laser surgeries
US11418000B2 (en) 2018-02-26 2022-08-16 Cynosure, Llc Q-switched cavity dumped sub-nanosecond laser

Families Citing this family (153)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688261A (en) 1990-11-07 1997-11-18 Premier Laser Systems, Inc. Transparent laser surgical probe
US5405368A (en) * 1992-10-20 1995-04-11 Esc Inc. Method and apparatus for therapeutic electromagnetic treatment
US5683380A (en) 1995-03-29 1997-11-04 Esc Medical Systems Ltd. Method and apparatus for depilation using pulsed electromagnetic radiation
US5720772A (en) * 1992-10-20 1998-02-24 Esc Medical Systems Ltd. Method and apparatus for therapeutic electromagnetic treatment
US5626631A (en) * 1992-10-20 1997-05-06 Esc Medical Systems Ltd. Method and apparatus for therapeutic electromagnetic treatment
US5620478A (en) * 1992-10-20 1997-04-15 Esc Medical Systems Ltd. Method and apparatus for therapeutic electromagnetic treatment
GB2272278B (en) * 1992-10-23 1997-04-09 Cancer Res Campaign Tech Light source
US5707403A (en) * 1993-02-24 1998-01-13 Star Medical Technologies, Inc. Method for the laser treatment of subsurface blood vessels
JPH06277227A (en) * 1993-03-26 1994-10-04 Toshiba Medical Eng Co Ltd Laser medical treatment device
JP3263275B2 (en) * 1994-04-05 2002-03-04 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Apparatus for laser treatment of living tissue and laser treatment apparatus for flame-like nevus
US5979454A (en) * 1995-05-15 1999-11-09 The Regents Of The University Of California Method and apparatus for causing rapid and deep spatially selective coagulation during thermally mediated therapeutic procedures
US6248103B1 (en) 1994-04-05 2001-06-19 The Regents Of The University Of California Apparatus and method for dynamic cooling of biological tissues for thermal mediated surgery using long laser pulses
US5522813A (en) * 1994-09-23 1996-06-04 Coherent, Inc. Method of treating veins
CA2206039A1 (en) * 1994-12-09 1996-06-13 Cynosure Inc. Near-infrared selective photothermolysis for vascular targets
US5558667A (en) * 1994-12-14 1996-09-24 Coherent, Inc. Method and apparatus for treating vascular lesions
US5599342A (en) * 1995-01-27 1997-02-04 Candela Laser Corporation Method for treating pigmentation abnormalities using pulsed laser radiation with an elongated cross-section and apparatus for providing same
US5735844A (en) * 1995-02-01 1998-04-07 The General Hospital Corporation Hair removal using optical pulses
US5611795A (en) * 1995-02-03 1997-03-18 Laser Industries, Ltd. Laser facial rejuvenation
US5868731A (en) * 1996-03-04 1999-02-09 Innotech Usa, Inc. Laser surgical device and method of its use
US5658323A (en) * 1995-07-12 1997-08-19 Miller; Iain D. Method and apparatus for dermatology treatment
US5879376A (en) * 1995-07-12 1999-03-09 Luxar Corporation Method and apparatus for dermatology treatment
US5746736A (en) * 1995-08-09 1998-05-05 Lumedics, Ltd. Cryogenic laser lithotripsy with enhanced light absorption
AU707065B2 (en) * 1995-08-29 1999-07-01 Nitto Denko Corporation Microporation of human skin for drug delivery and monitoring applications
US5849029A (en) * 1995-12-26 1998-12-15 Esc Medical Systems, Ltd. Method for controlling the thermal profile of the skin
US5964749A (en) * 1995-09-15 1999-10-12 Esc Medical Systems Ltd. Method and apparatus for skin rejuvenation and wrinkle smoothing
US5836999A (en) * 1995-09-28 1998-11-17 Esc Medical Systems Ltd. Method and apparatus for treating psoriasis using pulsed electromagnetic radiation
US5776175A (en) * 1995-09-29 1998-07-07 Esc Medical Systems Ltd. Method and apparatus for treatment of cancer using pulsed electromagnetic radiation
DE29517716U1 (en) * 1995-11-08 1996-01-25 Waldmann Gmbh & Co Herbert Device for photodynamic radiation
US6083217A (en) * 1995-11-29 2000-07-04 Lumedics, Ltd. Destruction for unwanted tissue by deep laser heating of water
US5897549A (en) * 1995-11-29 1999-04-27 Lumedics, Ltd. Transformation of unwanted tissue by deep laser heating of water
US5879346A (en) * 1995-12-18 1999-03-09 Esc Medical Systems, Ltd. Hair removal by selective photothermolysis with an alexandrite laser
US7022121B2 (en) 1999-03-09 2006-04-04 Thermage, Inc. Handpiece for treatment of tissue
US7189230B2 (en) * 1996-01-05 2007-03-13 Thermage, Inc. Method for treating skin and underlying tissue
US7473251B2 (en) * 1996-01-05 2009-01-06 Thermage, Inc. Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient
US5630811A (en) * 1996-03-25 1997-05-20 Miller; Iain D. Method and apparatus for hair removal
US5843072A (en) * 1996-11-07 1998-12-01 Cynosure, Inc. Method for treatment of unwanted veins and device therefor
US5871479A (en) * 1996-11-07 1999-02-16 Cynosure, Inc. Alexandrite laser system for hair removal and method therefor
US6547781B1 (en) * 1996-04-09 2003-04-15 Cynsure, Inc. Ultra-long flashlamp-excited pulse dye laser for therapy and method therefor
CN1220591A (en) 1996-04-09 1999-06-23 希诺索尔公司 Alexandrite laser system for treatment of dermatological specimens
US5662644A (en) * 1996-05-14 1997-09-02 Mdlt, Inc. Dermatological laser apparatus and method
US5976123A (en) * 1996-07-30 1999-11-02 Laser Aesthetics, Inc. Heart stabilization
US5820626A (en) * 1996-07-30 1998-10-13 Laser Aesthetics, Inc. Cooling laser handpiece with refillable coolant reservoir
US6096029A (en) * 1997-02-24 2000-08-01 Laser Skin Toner, Inc. Laser method for subsurface cutaneous treatment
US6214034B1 (en) * 1996-09-04 2001-04-10 Radiancy, Inc. Method of selective photothermolysis
US5908418A (en) * 1996-09-13 1999-06-01 Dority; Douglas B. Hand held coagulating device
US6306128B1 (en) 1996-10-09 2001-10-23 Laser Industries Ltd. Cooling apparatus for cutaneous treatment employing a laser and method for operating same
US7204832B2 (en) 1996-12-02 2007-04-17 Pálomar Medical Technologies, Inc. Cooling system for a photo cosmetic device
US6015404A (en) * 1996-12-02 2000-01-18 Palomar Medical Technologies, Inc. Laser dermatology with feedback control
US5830208A (en) * 1997-01-31 1998-11-03 Laserlite, Llc Peltier cooled apparatus and methods for dermatological treatment
US5810801A (en) * 1997-02-05 1998-09-22 Candela Corporation Method and apparatus for treating wrinkles in skin using radiation
DE19710676C2 (en) * 1997-03-16 1999-06-02 Aesculap Meditec Gmbh Arrangement for photoablation
EP1018955A4 (en) * 1997-06-24 2001-06-20 Laser Aesthetics Inc Pulsed filament lamp for dermatological treatment
US5885274A (en) 1997-06-24 1999-03-23 New Star Lasers, Inc. Filament lamp for dermatological treatment
US6413253B1 (en) 1997-08-16 2002-07-02 Cooltouch Corporation Subsurface heating of material
WO2000053261A1 (en) 1999-03-08 2000-09-14 Asah Medico A/S An apparatus for tissue treatment and having a monitor for display of tissue features
US6074382A (en) 1997-08-29 2000-06-13 Asah Medico A/S Apparatus for tissue treatment
US5968033A (en) * 1997-11-03 1999-10-19 Fuller Research Corporation Optical delivery system and method for subsurface tissue irradiation
US5885275A (en) * 1998-01-15 1999-03-23 Diomed, Inc. Medical spacing guide
US6575964B1 (en) 1998-02-03 2003-06-10 Sciton, Inc. Selective aperture for laser delivery system for providing incision, tissue ablation and coagulation
US6306130B1 (en) 1998-04-07 2001-10-23 The General Hospital Corporation Apparatus and methods for removing blood vessels
GB9807794D0 (en) * 1998-04-09 1998-06-10 Whitcroft Ian A Laser treatment cooling head
US6162210A (en) * 1998-08-06 2000-12-19 Shadduck; John H. Laser mediated treatments for presbyopia and hyperopia
WO2000023018A1 (en) * 1998-10-16 2000-04-27 Panagiotis Economides Tissue cooling system for use with laser probes
US6514242B1 (en) 1998-12-03 2003-02-04 David Vasily Method and apparatus for laser removal of hair
US6402739B1 (en) * 1998-12-08 2002-06-11 Y-Beam Technologies, Inc. Energy application with cooling
US6200308B1 (en) 1999-01-29 2001-03-13 Candela Corporation Dynamic cooling of tissue for radiation treatment
US6569155B1 (en) * 1999-03-15 2003-05-27 Altus Medical, Inc. Radiation delivery module and dermal tissue treatment method
US7041094B2 (en) 1999-03-15 2006-05-09 Cutera, Inc. Tissue treatment device and method
US6383176B1 (en) * 1999-03-15 2002-05-07 Altus Medical, Inc. Hair removal device and method
DE19914108A1 (en) 1999-03-23 2000-10-05 Plasmaphotonics Gmbh Irradiation arrangement, in particular for optical thermolysis
US6733492B2 (en) * 1999-05-31 2004-05-11 Nidek Co., Ltd. Laser treatment apparatus
US20040176718A1 (en) * 1999-06-07 2004-09-09 Joachim Fiedler Suction removal of waste products in the ablation of biological tissue
US6752778B1 (en) 1999-06-07 2004-06-22 Carl Zeiss Meditec Ag Removal of waste products by suction during the ablation of biological tissue
US6451007B1 (en) 1999-07-29 2002-09-17 Dale E. Koop Thermal quenching of tissue
DE19946177B4 (en) * 1999-09-21 2004-07-29 Asclepion-Meditec Ag Arrangement for the removal of ablation waste products
US6171105B1 (en) * 1999-09-21 2001-01-09 Eg&G Ilc Technology, Inc. Dental-restoration light-curing system
US6758845B1 (en) * 1999-10-08 2004-07-06 Lumenis Inc. Automatic firing apparatus and methods for laser skin treatment over large areas
ITFI990259A1 (en) * 1999-12-21 2001-06-21 Alberto Innocenti DEVICE AND METHOD FOR SKIN TREATMENT THROUGH A LASER SOURCE
WO2002013906A1 (en) * 2000-08-16 2002-02-21 Vanderbilt University Methods and devices for optical stimulation of neural tissues
ITMO20010008A1 (en) 2001-01-29 2002-07-29 Laserwave Srl DEVICE FOR SKIN TREATMENTS
JP4027049B2 (en) * 2001-02-28 2007-12-26 株式会社ニデック Laser therapy device
US6743221B1 (en) 2001-03-13 2004-06-01 James L. Hobart Laser system and method for treatment of biological tissues
DE60126678T2 (en) * 2001-03-30 2007-10-31 Cyden Ltd. THERAPEUTIC TREATMENT DEVICE
US20020165529A1 (en) * 2001-04-05 2002-11-07 Danek Christopher James Method and apparatus for non-invasive energy delivery
AU2002303863B2 (en) * 2001-05-23 2006-08-31 Palomar Medical Technologies, Inc. Cooling system for a photocosmetic device
CN102499755B (en) * 2001-05-23 2014-11-12 帕洛玛医疗技术公司 Cooling system for photocosmetic device
DE10129650A1 (en) * 2001-06-15 2003-01-02 Asclepion Meditec Ag Process and arrangement for material removal
US6770069B1 (en) 2001-06-22 2004-08-03 Sciton, Inc. Laser applicator
ES2287304T3 (en) * 2001-12-10 2007-12-16 Inolase 2002 Ltd. METHOD AND APPLIANCE FOR IMPROVING SECURITY DURING EXPOSURE TO A MONOCROMATIC LIGHT SOURCE.
US7762964B2 (en) * 2001-12-10 2010-07-27 Candela Corporation Method and apparatus for improving safety during exposure to a monochromatic light source
US7762965B2 (en) * 2001-12-10 2010-07-27 Candela Corporation Method and apparatus for vacuum-assisted light-based treatments of the skin
US7935139B2 (en) * 2001-12-10 2011-05-03 Candela Corporation Eye safe dermatological phototherapy
EP1627662B1 (en) 2004-06-10 2011-03-02 Candela Corporation Apparatus for vacuum-assisted light-based treatments of the skin
US7540869B2 (en) 2001-12-27 2009-06-02 Palomar Medical Technologies, Inc. Method and apparatus for improved vascular related treatment
CN100482182C (en) * 2002-06-19 2009-04-29 帕洛玛医疗技术公司 Method and apparatus for photothermal treatment of tissue at depth
GB2390025B (en) * 2002-06-28 2005-07-27 Lynton Lasers Ltd Dermatological treatment apparatus and method
US7740600B2 (en) * 2002-08-02 2010-06-22 Candela Corporation Apparatus and method for inhibiting pain signals transmitted during a skin related medical treatment
US20050177141A1 (en) * 2003-01-27 2005-08-11 Davenport Scott A. System and method for dermatological treatment gas discharge lamp with controllable current density
WO2004078034A2 (en) * 2003-03-04 2004-09-16 Spectragenics, Inc. Method and apparatus for the repigmentation of human skin
US7153298B1 (en) * 2003-03-28 2006-12-26 Vandolay, Inc. Vascular occlusion systems and methods
US7207985B2 (en) * 2003-06-25 2007-04-24 Endocare, Inc. Detachable cryosurgical probe
US7381207B2 (en) * 2003-06-25 2008-06-03 Endocare, Inc. Quick disconnect assembly having a finger lock assembly
US7291140B2 (en) 2003-07-18 2007-11-06 Cutera, Inc. System and method for low average power dermatologic light treatment device
US7722600B2 (en) 2003-08-25 2010-05-25 Cutera, Inc. System and method for heating skin using light to provide tissue treatment
US8870856B2 (en) 2003-08-25 2014-10-28 Cutera, Inc. Method for heating skin using light to provide tissue treatment
US8915906B2 (en) 2003-08-25 2014-12-23 Cutera, Inc. Method for treatment of post-partum abdominal skin redundancy or laxity
US7326199B2 (en) 2003-12-22 2008-02-05 Cutera, Inc. System and method for flexible architecture for dermatologic treatments utilizing multiple light sources
WO2005065565A1 (en) 2003-12-31 2005-07-21 Palomar Medical Technologies, Inc. Dermatological treatment with vusualization
US20070055224A1 (en) * 2004-04-29 2007-03-08 Lee Fred T Jr Intralumenal microwave device
US20070016181A1 (en) * 2004-04-29 2007-01-18 Van Der Weide Daniel W Microwave tissue resection tool
US20060276781A1 (en) * 2004-04-29 2006-12-07 Van Der Weide Daniel W Cannula cooling and positioning device
US7467015B2 (en) * 2004-04-29 2008-12-16 Neuwave Medical, Inc. Segmented catheter for tissue ablation
DE102004021680A1 (en) 2004-04-30 2005-11-24 Carl Zeiss Meditec Ag Arrangement for the removal of waste products during the ablation of biological tissue
US7842007B2 (en) 2004-04-30 2010-11-30 Clawson Burrell E Apparatus and methods for isolating human body areas for localized cooling
US7837675B2 (en) 2004-07-22 2010-11-23 Shaser, Inc. Method and device for skin treatment with replaceable photosensitive window
US7780656B2 (en) * 2004-12-10 2010-08-24 Reliant Technologies, Inc. Patterned thermal treatment using patterned cryogen spray and irradiation by light
US8277495B2 (en) 2005-01-13 2012-10-02 Candela Corporation Method and apparatus for treating a diseased nail
US20060281763A1 (en) * 2005-03-25 2006-12-14 Axon Jonathan R Carboxamide inhibitors of TGFbeta
US20060287662A1 (en) * 2005-05-26 2006-12-21 Ntk Enterprises, Inc. Device, system, and method for epithelium protection during cornea reshaping
US7874698B2 (en) * 2005-09-16 2011-01-25 Mullani Nizar A Transillumination having orange color light
US9028469B2 (en) 2005-09-28 2015-05-12 Candela Corporation Method of treating cellulite
US7891362B2 (en) 2005-12-23 2011-02-22 Candela Corporation Methods for treating pigmentary and vascular abnormalities in a dermal region
WO2007112102A1 (en) * 2006-03-24 2007-10-04 Micrablate Center fed dipole for use with tissue ablation systems, devices, and methods
EP1998698B1 (en) * 2006-03-24 2020-12-23 Neuwave Medical, Inc. Transmission line with heat transfer ability
EP1849497A1 (en) * 2006-04-26 2007-10-31 Koninklijke Philips Electronics N.V. Tanning apparatus
US8460280B2 (en) * 2006-04-28 2013-06-11 Cutera, Inc. Localized flashlamp skin treatments
US8246611B2 (en) 2006-06-14 2012-08-21 Candela Corporation Treatment of skin by spatial modulation of thermal heating
US10376314B2 (en) 2006-07-14 2019-08-13 Neuwave Medical, Inc. Energy delivery systems and uses thereof
US11389235B2 (en) * 2006-07-14 2022-07-19 Neuwave Medical, Inc. Energy delivery systems and uses thereof
US9050117B2 (en) * 2006-08-28 2015-06-09 The Regents Of The University Of California Dynamic cooling of human skin using a nontoxic cryogen with no ozone depletion and minimal global warming potential
US20100324544A1 (en) * 2006-10-23 2010-12-23 Koninklijke Philips Electronics N.V. Optical treatment system and an adjustment member therefor
US7740651B2 (en) * 2007-09-28 2010-06-22 Candela Corporation Vacuum assisted treatment of the skin
DE102007047501A1 (en) * 2007-10-04 2009-04-09 Rolle + Rolle Gmbh + Co. Kg Laserfokussierhandstück
US8920409B2 (en) * 2007-10-04 2014-12-30 Cutera, Inc. System and method for dermatological lesion treatment using gas discharge lamp with controllable current density
FR2935884A1 (en) * 2008-09-12 2010-03-19 Dermeo HAND PIECE WITH OPTICAL BLOCK OF SKIN PHOTOTRAITEMENT APPARATUS
GB2470927A (en) * 2009-06-10 2010-12-15 Dezac Group Ltd Phototherapy apparatus with skin temperature control
CN106214246A (en) 2009-07-28 2016-12-14 纽韦弗医疗设备公司 Energy delivery system and use thereof
CA2800312C (en) 2010-05-03 2021-01-19 Neuwave Medical, Inc. Energy delivery systems and uses thereof
RU2496442C2 (en) * 2011-12-12 2013-10-27 Федеральное государственное бюджетное учреждение науки Институт физики твердого тела Российской академии наук (ИФТТ РАН) Cryonozzle with sapphire cold conductor-irradiator
EP3769712A1 (en) 2011-12-21 2021-01-27 Neuwave Medical, Inc. Energy delivery systems
US9149332B2 (en) * 2012-02-01 2015-10-06 Lumenis Ltd. Reconfigurable handheld laser treatment systems and methods
WO2014003855A1 (en) 2012-06-27 2014-01-03 Monteris Medical Corporation Image-guided therapy of a tissue
US10675113B2 (en) 2014-03-18 2020-06-09 Monteris Medical Corporation Automated therapy of a three-dimensional tissue region
WO2015143025A1 (en) 2014-03-18 2015-09-24 Monteris Medical Corporation Image-guided therapy of a tissue
US9504484B2 (en) 2014-03-18 2016-11-29 Monteris Medical Corporation Image-guided therapy of a tissue
WO2015179288A1 (en) 2014-05-19 2015-11-26 University Of South Florida Systems and methods for analyzing liquids
US10327830B2 (en) 2015-04-01 2019-06-25 Monteris Medical Corporation Cryotherapy, thermal therapy, temperature modulation therapy, and probe apparatus therefor
MX2018005116A (en) 2015-10-26 2018-09-05 Neuwave Medical Inc Energy delivery systems and uses thereof.
KR101710094B1 (en) * 2016-01-14 2017-02-27 주식회사 비앤비시스템 Coupler for laser handpiece using in dentist
CN109069203B (en) 2016-04-15 2021-06-22 纽韦弗医疗设备公司 System and method for energy delivery
US11672596B2 (en) 2018-02-26 2023-06-13 Neuwave Medical, Inc. Energy delivery devices with flexible and adjustable tips
US11832879B2 (en) 2019-03-08 2023-12-05 Neuwave Medical, Inc. Systems and methods for energy delivery
US20220266053A1 (en) * 2019-12-23 2022-08-25 Teijin Pharma Limited Phototherapy device

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3693623A (en) * 1970-12-25 1972-09-26 Gregory System Inc Photocoagulation means and method for depilation
US3821510A (en) * 1973-02-22 1974-06-28 H Muncheryan Hand held laser instrumentation device
US4316467A (en) * 1980-06-23 1982-02-23 Lorenzo P. Maun Control for laser hemangioma treatment system
US4539987A (en) * 1980-02-27 1985-09-10 Nath Guenther Apparatus for coagulation by heat radiation
US4733660A (en) * 1984-08-07 1988-03-29 Medical Laser Research And Development Corporation Laser system for providing target specific energy deposition and damage
US5057104A (en) * 1989-05-30 1991-10-15 Cyrus Chess Method and apparatus for treating cutaneous vascular lesions
US5071417A (en) * 1990-06-15 1991-12-10 Rare Earth Medical Lasers, Inc. Laser fusion of biological materials
US5112328A (en) * 1988-01-25 1992-05-12 Refractive Laser Research & Development Program, Ltd. Method and apparatus for laser surgery
US5405368A (en) * 1992-10-20 1995-04-11 Esc Inc. Method and apparatus for therapeutic electromagnetic treatment
US5626631A (en) * 1992-10-20 1997-05-06 Esc Medical Systems Ltd. Method and apparatus for therapeutic electromagnetic treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63216579A (en) * 1987-03-05 1988-09-08 大工園 則雄 Laser beam irradiation apparatus for hyperthermia

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3693623A (en) * 1970-12-25 1972-09-26 Gregory System Inc Photocoagulation means and method for depilation
US3821510A (en) * 1973-02-22 1974-06-28 H Muncheryan Hand held laser instrumentation device
US4539987A (en) * 1980-02-27 1985-09-10 Nath Guenther Apparatus for coagulation by heat radiation
US4316467A (en) * 1980-06-23 1982-02-23 Lorenzo P. Maun Control for laser hemangioma treatment system
US4733660A (en) * 1984-08-07 1988-03-29 Medical Laser Research And Development Corporation Laser system for providing target specific energy deposition and damage
US5112328A (en) * 1988-01-25 1992-05-12 Refractive Laser Research & Development Program, Ltd. Method and apparatus for laser surgery
US5057104A (en) * 1989-05-30 1991-10-15 Cyrus Chess Method and apparatus for treating cutaneous vascular lesions
US5282797A (en) * 1989-05-30 1994-02-01 Cyrus Chess Method for treating cutaneous vascular lesions
US5071417A (en) * 1990-06-15 1991-12-10 Rare Earth Medical Lasers, Inc. Laser fusion of biological materials
US5405368A (en) * 1992-10-20 1995-04-11 Esc Inc. Method and apparatus for therapeutic electromagnetic treatment
US5626631A (en) * 1992-10-20 1997-05-06 Esc Medical Systems Ltd. Method and apparatus for therapeutic electromagnetic treatment

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Anvari et al, "Selective cooling . . . procedures", Phys. Med. Biol., vol 40, pp. 241-252. 1995.
Anvari et al, Selective cooling . . . procedures , Phys. Med. Biol., vol 40, pp. 241 252. 1995. *

Cited By (173)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030069567A1 (en) * 1992-10-20 2003-04-10 Shimon Eckhouse Method and apparatus for electromagnetic treatment of the skin, including hair depilation
US7108689B2 (en) 1992-10-20 2006-09-19 Lumenis Ltd Method and apparatus for electromagnetic treatment of the skin, including hair depilation
US20040034346A1 (en) * 1996-01-05 2004-02-19 Stern Roger A. RF device with thermo-electric cooler
US8685017B2 (en) 1996-01-05 2014-04-01 Thermage, Inc. Method and kit for treatment of tissue
US20070255274A1 (en) * 1996-01-05 2007-11-01 Thermage, Inc. Method and kit for treatment of tissue
US20040000316A1 (en) * 1996-01-05 2004-01-01 Knowlton Edward W. Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient
US20040030332A1 (en) * 1996-01-05 2004-02-12 Knowlton Edward W. Handpiece with electrode and non-volatile memory
US20030212393A1 (en) * 1996-01-05 2003-11-13 Knowlton Edward W. Handpiece with RF electrode and non-volatile memory
US20040002704A1 (en) * 1996-01-05 2004-01-01 Knowlton Edward W. Treatment apparatus with electromagnetic energy delivery device and non-volatile memory
US8328794B2 (en) 1996-12-02 2012-12-11 Palomar Medical Technologies, Inc. System for electromagnetic radiation dermatology and head for use therewith
US20030065314A1 (en) * 1996-12-02 2003-04-03 Palomar Medical Technologies, Inc. System for electromagnetic radiation dermatology and head for use therewith
US6508813B1 (en) 1996-12-02 2003-01-21 Palomar Medical Technologies, Inc. System for electromagnetic radiation dermatology and head for use therewith
US20080139901A1 (en) * 1996-12-02 2008-06-12 Palomar Medical Technologies, Inc. Cooling System For A Photocosmetic Device
US20080294153A1 (en) * 1996-12-02 2008-11-27 Palomar Medical Technologies, Inc. Cooling System For A Photocosmetic Device
US8002768B1 (en) 1997-05-15 2011-08-23 Palomar Medical Technologies, Inc. Light energy delivery head
US6976985B2 (en) 1997-05-15 2005-12-20 Palomar Medical Technologies, Inc. Light energy delivery head
US6663620B2 (en) 1997-05-15 2003-12-16 Palomar Medical Technologies, Inc. Light energy delivery head
US7077840B2 (en) * 1997-05-15 2006-07-18 Palomar Medical Technologies, Inc. Heads for dermatology treatment
US20060161143A1 (en) * 1997-05-15 2006-07-20 Palomar Medical Technologies, Inc. Light energy delivery head
US20060287646A1 (en) * 1997-05-15 2006-12-21 Palomar Medical Technologies, Inc. Method and apparatus for therapeutic EMR treatment on the skin
US20030195494A1 (en) * 1997-05-15 2003-10-16 Altshuler Gregory B. Light energy delivery head
US6517532B1 (en) 1997-05-15 2003-02-11 Palomar Medical Technologies, Inc. Light energy delivery head
US20030055414A1 (en) * 1997-05-15 2003-03-20 Altshuler Gregory B. Heads for dermatology treatment
US7935107B2 (en) 1997-05-15 2011-05-03 Palomar Medical Technologies, Inc. Heads for dermatology treatment
US7763016B2 (en) 1997-05-15 2010-07-27 Palomar Medical Technologies, Inc. Light energy delivery head
US8109924B2 (en) 1997-05-15 2012-02-07 Palomar Medical Technologies, Inc. Heads for dermatology treatment
US7758621B2 (en) 1997-05-15 2010-07-20 Palomar Medical Technologies, Inc. Method and apparatus for therapeutic EMR treatment on the skin
US6511475B1 (en) 1997-05-15 2003-01-28 The General Hospital Corporation Heads for dermatology treatment
US8328796B2 (en) 1997-05-15 2012-12-11 Palomar Medical Technologies, Inc. Light energy delivery head
US6273885B1 (en) * 1997-08-16 2001-08-14 Cooltouch Corporation Handheld photoepilation device and method
US20060197247A1 (en) * 1998-02-12 2006-09-07 Moldflow Pty Ltd Automated Molding Technology For Thermoplastic Injection Molding
US7060061B2 (en) 1998-03-27 2006-06-13 Palomar Medical Technologies, Inc. Method and apparatus for the selective targeting of lipid-rich tissues
US6605080B1 (en) 1998-03-27 2003-08-12 The General Hospital Corporation Method and apparatus for the selective targeting of lipid-rich tissues
US20030199859A1 (en) * 1998-03-27 2003-10-23 Altshuler Gregory B. Method and apparatus for the selective targeting of lipid-rich tissues
USRE42594E1 (en) 1998-10-16 2011-08-02 Reliant Technologies, Inc. Tissue cooling rod for laser surgery
USRE46208E1 (en) 1998-10-16 2016-11-22 Reliant Technologies, Llc Method for cryogenically treating tissue below the skin surface
USRE43881E1 (en) 1998-10-16 2012-12-25 Reliant Technologies, Inc. Tissue cooling rod for laser surgery
US9113900B2 (en) 1998-10-23 2015-08-25 Covidien Ag Method and system for controlling output of RF medical generator
US9168089B2 (en) 1998-10-23 2015-10-27 Covidien Ag Method and system for controlling output of RF medical generator
US6682524B1 (en) * 1998-11-12 2004-01-27 Asclepion Laser Technologies Gmbh Dermatological hand piece
US20070129711A1 (en) * 1999-01-08 2007-06-07 Altshuler Gregory B Cooling system for a photocosmetic device
US8182473B2 (en) 1999-01-08 2012-05-22 Palomar Medical Technologies Cooling system for a photocosmetic device
US20070010811A1 (en) * 1999-03-09 2007-01-11 Thermage, Inc. energy delivery device for treating tissue
US20050215988A1 (en) * 2000-01-25 2005-09-29 Palomar Medical Technologies, Inc. Method and apparatus for medical treatment utilizing long duration electromagnetic radiation
US6436094B1 (en) * 2000-03-16 2002-08-20 Laserscope, Inc. Electromagnetic and laser treatment and cooling device
US6653618B2 (en) 2000-04-28 2003-11-25 Palomar Medical Technologies, Inc. Contact detecting method and apparatus for an optical radiation handpiece
US7083610B1 (en) * 2000-06-07 2006-08-01 Laserscope Device for irradiating tissue
US7452355B2 (en) * 2000-09-12 2008-11-18 Vladimir Valentinovich Khomchenko Method of laser coagulation of blood vessels
US20050203491A1 (en) * 2000-09-12 2005-09-15 Khomchenko Vladimir V. Method of laser coagulation of blood vessels
US20070282402A1 (en) * 2000-10-20 2007-12-06 Photomedex Treatment of skin disorders with uv light and cooling
US7886749B2 (en) 2000-10-20 2011-02-15 Photomedex Treatment of skin disorders with UV light and cooling
US8486056B2 (en) 2000-10-20 2013-07-16 Photomedex Treatment of skin disorders with UV light
US7276059B2 (en) * 2000-10-20 2007-10-02 Photomedex Treatment of skin disorders with UV light and cooling
US20050015124A1 (en) * 2000-10-20 2005-01-20 Irwin Dean S. Treatment of skin disorders with UV light and cooling
US20060276862A1 (en) * 2000-10-20 2006-12-07 Irwin Dean S Treatment of skin disorders with UV light and cooling
US9162078B2 (en) 2000-10-20 2015-10-20 Mela Sciences, Inc. Treatment of skin disorders with UV light
US20110004280A1 (en) * 2000-10-20 2011-01-06 Photomedex Treatment of skin disorders with uv light
US20080183162A1 (en) * 2000-12-28 2008-07-31 Palomar Medical Technologies, Inc. Methods And Devices For Fractional Ablation Of Tissue
US20060058712A1 (en) * 2000-12-28 2006-03-16 Palomar Medical Technologies, Inc. Methods and products for producing lattices of EMR-treated islets in tissues, and uses therefor
US6997923B2 (en) 2000-12-28 2006-02-14 Palomar Medical Technologies, Inc. Method and apparatus for EMR treatment
US20080033413A1 (en) * 2001-03-01 2008-02-07 Palomar Medical Technologies, Inc. Flashlamp drive circuit
US20060009750A1 (en) * 2001-03-02 2006-01-12 Palomar Medical Technologies, Inc. Apparatus and method for treatment using a patterned mask
US20060206103A1 (en) * 2001-03-02 2006-09-14 Palomar Medical Technologies, Inc. Dermatological treatment device
US6723090B2 (en) 2001-07-02 2004-04-20 Palomar Medical Technologies, Inc. Fiber laser device for medical/cosmetic procedures
US20060111760A1 (en) * 2001-08-10 2006-05-25 Lajos Kemeny Phototherapeutical method and system for the treatment of inflammatory and hyperproliferative disorders of the nasal mucosa
US7891361B2 (en) 2001-10-18 2011-02-22 Photomedex Methods for UV photo-therapy
US7144248B2 (en) 2001-10-18 2006-12-05 Irwin Dean S Device for oral UV photo-therapy
US20080288032A1 (en) * 2001-10-18 2008-11-20 Photomedex Device for UV photo-therapy
US20050177208A1 (en) * 2001-10-18 2005-08-11 Irwin Dean S. Device for oral UV photo-therapy
US8454669B2 (en) 2001-10-18 2013-06-04 Photomedex Device for UV photo-therapy
US20110196457A1 (en) * 2001-10-18 2011-08-11 Photomedex Device for uv photo-therapy
US10758743B2 (en) 2001-11-01 2020-09-01 Pthera LLC Method for providing phototherapy to the brain
US20040147984A1 (en) * 2001-11-29 2004-07-29 Palomar Medical Technologies, Inc. Methods and apparatus for delivering low power optical treatments
US20050049582A1 (en) * 2001-12-12 2005-03-03 Debenedictis Leonard C. Method and apparatus for fractional photo therapy of skin
US20030109860A1 (en) * 2001-12-12 2003-06-12 Michael Black Multiple laser treatment
US10695577B2 (en) 2001-12-21 2020-06-30 Photothera, Inc. Device and method for providing phototherapy to the heart
US20040260367A1 (en) * 2001-12-21 2004-12-23 Luis De Taboada Device and method for providing phototherapy to the heart
US20040034319A1 (en) * 2002-03-12 2004-02-19 Palomar Medical Technologies, Inc. Method and apparatus for hair growth management
US7942916B2 (en) 2002-05-23 2011-05-17 Palomar Medical Technologies, Inc. Phototreatment device for use with coolants and topical substances
US7942915B2 (en) 2002-05-23 2011-05-17 Palomar Medical Technologies, Inc. Phototreatment device for use with coolants
US20070067006A1 (en) * 2002-05-23 2007-03-22 Palomar Medical Technologies, Inc. Phototreatment device for use with coolants
US20030233138A1 (en) * 2002-06-12 2003-12-18 Altus Medical, Inc. Concentration of divergent light from light emitting diodes into therapeutic light energy
US10500413B2 (en) 2002-06-19 2019-12-10 Palomar Medical Technologies, Llc Method and apparatus for treatment of cutaneous and subcutaneous conditions
US10556123B2 (en) 2002-06-19 2020-02-11 Palomar Medical Technologies, Llc Method and apparatus for treatment of cutaneous and subcutaneous conditions
US20040073079A1 (en) * 2002-06-19 2004-04-15 Palomar Medical Technologies, Inc. Method and apparatus for treatment of cutaneous and subcutaneous conditions
US8915948B2 (en) 2002-06-19 2014-12-23 Palomar Medical Technologies, Llc Method and apparatus for photothermal treatment of tissue at depth
US20040082940A1 (en) * 2002-10-22 2004-04-29 Michael Black Dermatological apparatus and method
US20050107851A1 (en) * 2002-11-01 2005-05-19 Taboada Luis D. Device and method for providing phototherapy to the brain
US20040162549A1 (en) * 2002-11-12 2004-08-19 Palomar Medical Technologies, Inc. Method and apparatus for performing optical dermatology
US6991644B2 (en) 2002-12-12 2006-01-31 Cutera, Inc. Method and system for controlled spatially-selective epidermal pigmentation phototherapy with UVA LEDs
US20040116984A1 (en) * 2002-12-12 2004-06-17 Greg Spooner Method and system for controlled spatially-selective epidermal pigmentation phototherapy with UVA LEDs
US20060089687A1 (en) * 2002-12-12 2006-04-27 Greg Spooner System for controlled spatially-selective epidermal pigmentation phototherapy with UVA LEDs
US20100204686A1 (en) * 2002-12-20 2010-08-12 Palomar Medical Technologies, Inc. Light treatments for acne and other disorders of follicles
US7147654B2 (en) 2003-01-24 2006-12-12 Laserscope Treatment Site Cooling System of Skin Disorders
US7413567B2 (en) 2003-02-25 2008-08-19 Spectragenics, Inc. Optical sensor and method for identifying the presence of skin
US7250045B2 (en) 2003-02-25 2007-07-31 Spectragenics, Inc. Self-contained, eye-safe hair-regrowth-inhibition apparatus and method
US7981111B2 (en) 2003-02-25 2011-07-19 Tria Beauty, Inc. Method and apparatus for the treatment of benign pigmented lesions
US10342617B2 (en) 2003-02-25 2019-07-09 Channel Investments, Llc Phototherapy device thermal control apparatus and method
US7452356B2 (en) 2003-02-25 2008-11-18 Tria Beauty, Inc. Eye-safe dermatologic treatment apparatus
US20100069898A1 (en) * 2003-02-25 2010-03-18 Tria Beauty, Inc. Acne Treatment Method, System and Device
US8551104B2 (en) 2003-02-25 2013-10-08 Tria Beauty, Inc. Self-contained, diode-laser-based dermatologic treatment apparatus
US7118563B2 (en) * 2003-02-25 2006-10-10 Spectragenics, Inc. Self-contained, diode-laser-based dermatologic treatment apparatus
US20090043294A1 (en) * 2003-02-25 2009-02-12 Spectragenics, Inc. Capacitive Sensing Method and Device for Detecting Skin
US8709003B2 (en) 2003-02-25 2014-04-29 Tria Beauty, Inc. Capacitive sensing method and device for detecting skin
US20070032847A1 (en) * 2003-02-25 2007-02-08 Spectragenics, Inc. Self-contained, diode-laser-based dermatologic treatment apparatus
US10342618B2 (en) 2003-02-25 2019-07-09 Channel Investments, Llc Self-contained, eye-safe hair-regrowth-inhibition apparatus and method
US20090204109A1 (en) * 2003-02-25 2009-08-13 Tria Beauty, Inc. Eye-Safe Dermatologic Treatment Apparatus and Method
US20040167500A1 (en) * 2003-02-25 2004-08-26 Weckwerth Mark V. Self-contained, diode-laser-based dermatologic treatment apparatus and method
US9351792B2 (en) 2003-03-27 2016-05-31 The General Hospital Corporation Method and apparatus for dermatological treatment and fractional skin resurfacing
US20060155266A1 (en) * 2003-03-27 2006-07-13 Dieter Manstein Method and apparatus for dermatological treatment and fractional skin resurfacing
US20050137658A1 (en) * 2003-12-17 2005-06-23 Hennings David R. Treatment of superficial pigmented and vascular lesions of the skin
US7282060B2 (en) 2003-12-23 2007-10-16 Reliant Technologies, Inc. Method and apparatus for monitoring and controlling laser-induced tissue treatment
US20080043306A1 (en) * 2003-12-31 2008-02-21 Debenedictis Leonard C High Speed, High Efficiency Optical Pattern Generator Using Rotating Optical Elements
US7372606B2 (en) 2003-12-31 2008-05-13 Reliant Technologies, Inc. Optical pattern generator using a single rotating component
US7636186B2 (en) 2003-12-31 2009-12-22 Reliant Technologies, Inc. High speed, high efficiency optical pattern generator using rotating optical elements
US20050141068A1 (en) * 2003-12-31 2005-06-30 Debenedictis Leonard C. High speed, high efficiency optical pattern generator using rotating optical elements
US20050143719A1 (en) * 2003-12-31 2005-06-30 Sink Robert K. Multi-spot laser surgical apparatus and method
US7184184B2 (en) 2003-12-31 2007-02-27 Reliant Technologies, Inc. High speed, high efficiency optical pattern generator using rotating optical elements
US20050259306A1 (en) * 2003-12-31 2005-11-24 Broome Barry G Two-dimensional optical scan system using a counter-rotating disk scanner
US7480086B2 (en) 2003-12-31 2009-01-20 Reliant Technologies, Inc. High speed, high efficiency optical pattern generator using rotating optical elements
US20080068694A1 (en) * 2003-12-31 2008-03-20 Reliant Technologies, Inc. High speed, high efficiency optical pattern generator using rotating optical elements
US7411711B2 (en) 2003-12-31 2008-08-12 Reliant Technologies, Inc. High speed, high efficiency optical pattern generator using rotating optical elements
US20060276778A1 (en) * 2003-12-31 2006-12-07 Reliant Technologies, Inc. Multi-Spot Laser Surgical Apparatus and Method
US7090670B2 (en) 2003-12-31 2006-08-15 Reliant Technologies, Inc. Multi-spot laser surgical apparatus and method
US7196831B2 (en) 2003-12-31 2007-03-27 Reliant Technologies, Inc. Two-dimensional optical scan system using a counter-rotating disk scanner
US20090125006A1 (en) * 2004-02-25 2009-05-14 Spectragenics, Inc. Optical Sensor and Method for Identifying the Presence of Skin
US8777935B2 (en) 2004-02-25 2014-07-15 Tria Beauty, Inc. Optical sensor and method for identifying the presence of skin
US9452013B2 (en) 2004-04-01 2016-09-27 The General Hospital Corporation Apparatus for dermatological treatment using chromophores
US8268332B2 (en) 2004-04-01 2012-09-18 The General Hospital Corporation Method for dermatological treatment using chromophores
US20060020309A1 (en) * 2004-04-09 2006-01-26 Palomar Medical Technologies, Inc. Methods and products for producing lattices of EMR-treated islets in tissues, and uses therefor
US20060004306A1 (en) * 2004-04-09 2006-01-05 Palomar Medical Technologies, Inc. Methods and products for producing lattices of EMR-treated islets in tissues, and uses therefor
US20050278002A1 (en) * 2004-06-14 2005-12-15 David Eimerl Adaptive control of optical pulses for laser medicine
US20090137994A1 (en) * 2004-06-14 2009-05-28 Rellant Technologies, Inc, Adaptive control of optical pulses for laser medicine
US7413572B2 (en) 2004-06-14 2008-08-19 Reliant Technologies, Inc. Adaptive control of optical pulses for laser medicine
US8291913B2 (en) 2004-06-14 2012-10-23 Reliant Technologies, Inc. Adaptive control of optical pulses for laser medicine
US20070038206A1 (en) * 2004-12-09 2007-02-15 Palomar Medical Technologies, Inc. Photocosmetic device
US20060253176A1 (en) * 2005-02-18 2006-11-09 Palomar Medical Technologies, Inc. Dermatological treatment device with deflector optic
US20060271028A1 (en) * 2005-02-18 2006-11-30 Palomar Medical Technologies, Inc. Dermatological treatment device
US10434324B2 (en) 2005-04-22 2019-10-08 Cynosure, Llc Methods and systems for laser treatment using non-uniform output beam
US8346347B2 (en) 2005-09-15 2013-01-01 Palomar Medical Technologies, Inc. Skin optical characterization device
US20070194717A1 (en) * 2006-02-17 2007-08-23 Palomar Medical Technologies, Inc. Lamp for use in a tissue treatment device
US20070239142A1 (en) * 2006-03-10 2007-10-11 Palomar Medical Technologies, Inc. Photocosmetic device
US20070213696A1 (en) * 2006-03-10 2007-09-13 Palomar Medical Technologies, Inc. Photocosmetic device
US20070219605A1 (en) * 2006-03-20 2007-09-20 Palomar Medical Technologies, Inc. Treatment of tissue volume with radiant energy
US20070219604A1 (en) * 2006-03-20 2007-09-20 Palomar Medical Technologies, Inc. Treatment of tissue with radiant energy
US20070255355A1 (en) * 2006-04-06 2007-11-01 Palomar Medical Technologies, Inc. Apparatus and method for skin treatment with compression and decompression
US7691099B2 (en) 2006-07-12 2010-04-06 Ntk Enterprises, Inc. Deuterated ocular solutions for LTK and other surgical eye procedures
US10966785B2 (en) 2006-08-02 2021-04-06 Cynosure, Llc Picosecond laser apparatus and methods for its operation and use
US11712299B2 (en) 2006-08-02 2023-08-01 Cynosure, LLC. Picosecond laser apparatus and methods for its operation and use
US10849687B2 (en) 2006-08-02 2020-12-01 Cynosure, Llc Picosecond laser apparatus and methods for its operation and use
US9028536B2 (en) 2006-08-02 2015-05-12 Cynosure, Inc. Picosecond laser apparatus and methods for its operation and use
US20080161745A1 (en) * 2006-09-08 2008-07-03 Oliver Stumpp Bleaching of contrast enhancing agent applied to skin for use with a dermatological treatment system
US20080161782A1 (en) * 2006-10-26 2008-07-03 Reliant Technologies, Inc. Micropore delivery of active substances
US20080186591A1 (en) * 2007-02-01 2008-08-07 Palomar Medical Technologies, Inc. Dermatological device having a zoom lens system
US20090054879A1 (en) * 2007-08-23 2009-02-26 Ntk Enterprises, Inc. System and method for defining and controlling ltk and other surgical eye procedures to produce little or no stromal collagen shrinkage
US8603081B2 (en) 2007-08-23 2013-12-10 Ntk Enterprises, Inc. System and method for defining and controlling LTK and other surgical eye procedures to produce little or no stromal collagen shrinkage
US20090270848A1 (en) * 2008-04-25 2009-10-29 Tria Beauty, Inc. Optical Sensor and Method for Identifying the Presence of Skin and the Pigmentation of Skin
US9687671B2 (en) 2008-04-25 2017-06-27 Channel Investments, Llc Optical sensor and method for identifying the presence of skin and the pigmentation of skin
US9919168B2 (en) 2009-07-23 2018-03-20 Palomar Medical Technologies, Inc. Method for improvement of cellulite appearance
US9113934B2 (en) 2011-05-16 2015-08-25 Covidien Lp Optical energy-based methods and apparatus for tissue sealing
US9780518B2 (en) 2012-04-18 2017-10-03 Cynosure, Inc. Picosecond laser apparatus and methods for treating target tissues with same
US10581217B2 (en) 2012-04-18 2020-03-03 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US10305244B2 (en) 2012-04-18 2019-05-28 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US11095087B2 (en) 2012-04-18 2021-08-17 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US11664637B2 (en) 2012-04-18 2023-05-30 Cynosure, Llc Picosecond laser apparatus and methods for treating target tissues with same
US9833285B2 (en) 2012-07-17 2017-12-05 Covidien Lp Optical sealing device with cutting ability
US10765478B2 (en) 2013-03-15 2020-09-08 Cynosurce, Llc Picosecond optical radiation systems and methods of use
US10245107B2 (en) 2013-03-15 2019-04-02 Cynosure, Inc. Picosecond optical radiation systems and methods of use
US11446086B2 (en) 2013-03-15 2022-09-20 Cynosure, Llc Picosecond optical radiation systems and methods of use
US10285757B2 (en) 2013-03-15 2019-05-14 Cynosure, Llc Picosecond optical radiation systems and methods of use
US11418000B2 (en) 2018-02-26 2022-08-16 Cynosure, Llc Q-switched cavity dumped sub-nanosecond laser
US11791603B2 (en) 2018-02-26 2023-10-17 Cynosure, LLC. Q-switched cavity dumped sub-nanosecond laser
US10799292B2 (en) 2018-05-04 2020-10-13 Bin Rao High power tunable optical parametric oscillator for selective photothermolysis laser surgeries

Also Published As

Publication number Publication date
US5344418A (en) 1994-09-06

Similar Documents

Publication Publication Date Title
USRE36634E (en) Optical system for treatment of vascular lesions
US8474463B2 (en) Methods and devices for non-ablative laser treatment of dermatologic conditions
US6666856B2 (en) Hair removal device and method
US7618414B2 (en) Tissue treatment system
US7637906B2 (en) Thermal quenching of tissue
AU742982B2 (en) Pulsed filament lamp for dermatological treatment
US5968034A (en) Pulsed filament lamp for dermatological treatment
US5683380A (en) Method and apparatus for depilation using pulsed electromagnetic radiation
US5836999A (en) Method and apparatus for treating psoriasis using pulsed electromagnetic radiation
US5885273A (en) Method for depilation using pulsed electromagnetic radiation
US20020045891A1 (en) Wrinkle reduction
KR20010109307A (en) Skin wrinkle reduction using pulsed light
WO2001074265A1 (en) Dual-wavelength laser-treatment of vascular disorders
EP1042033A1 (en) Apparatus for therapeutic electromagnetic treatment
EP1659966A1 (en) Method and apparatus for reducing the appearance of skin markings
Wheeland Basic laser physics and safety
Hare et al. Basic laser: physics and safety
EP4260418A1 (en) Dermatological laser systems and methods for treatment of tissue with poor chromophore selectivity
Renton Metal vapor lasers for medical applications
Goldberg Flashlamp-excited dye laser therapy for treatment of cutaneous vascular lesions
Davis et al. A practical comparison of IPLs and the Copper Bromide Laser for photorejuvenation, acne and the treatment of vascular & pigmented lesions.

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FEPP Fee payment procedure

Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

FEPP Fee payment procedure

Free format text: PETITION RELATED TO MAINTENANCE FEES FILED (ORIGINAL EVENT CODE: PMFP); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

LAPS Lapse for failure to pay maintenance fees